case_id,patient_filename,text,summ,corrected
TCGA-B6-A0RO,TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF,"Patien. surgical F. CLINICAL HISTORY: Right breast Ca, rule out deep margin positive. GROSS EXAMINATION: A. ""#1 right modified radical mastectomy"", in formalin. Received in the. container is a portion of breast with an attached skin ellipse containing the. nipple and an axillary dissection. The specimen measures 18.5 x 14 x 3.9 cm. The attached skin ellipse measures 14.7 x 6.3 cm. The nipple appears grossly. unremarkable. There is a small 0.5 cm hole 1.7 cm inferior to the nipple. The. deep surface of the specimen is inked in blue and the specimen is serially. sectioned revealing a 3.5 x 2 x 1.5 cm firm white mass in the medial portion. of the specimen. The mass is fairly well-circumscribed but very firm to. palpation. Grossly it appears to approach within 0.2 cm of the deep surgical. margin. There is no definite biopsy cavity; however, there is a small area of. hemorrhage just adjacent to the tumor mass. Tissue from the tumor mass has. been sent for estrogen and progesterone receptors. Block Summary: A1- section through nipple. A2- section through hole in skin ellipse. A3-A5- sections of tumor with adjacent deep margin. A6-A9- representative sections of tumor. A10- representative sections of upper lateral quadrant. A11- representative section of lower lateral quadrant. A12- representative section of upper medial quadrant. A13- five lymph node candidates from level three. A14-A15- one large lymph node bisected, level three. A16- one large lymph node bisected and one small lymph node candidate, level. three. A17- one lymph node candidate bisected, level three. A18- one lymph node candidate bisected, level three. A19- four lymph node candidates from level II. A20- one lymph node candidate bisected from level II. A21- two lymph node candidates from level II. A22- five lymph node candidates from level I. A23- two lymph node candidates from level I. A24- two lymph node candidates from level I. A25- two lymph node candidates from level I. MICROSCOPIC EXAMINATION: Most of the tumor consists of tubules and cribriform glands composed of. atypical cells with a moderate amount of eosinophilic cytoplasm and oval. nuclei with distinct relatively small nucleoli. There is a sparse. inflammatory response. A minor non-comedo intraductal component is present,. within or near the tumor mass. Away from the tumor, no intraductal carcinoma. or epithelial hyperplasia is seen. DIAGNOSIS: A. ""RIGHT"" BREAST, MODIFIED RADICAL MASTECTOMY: INFILTRATING DUCTAL CARCINOMA (2.5 CM), NSABP HISTOLOGIC GRADE II/III,. NUCLEAR GRADE MODERATELY DIFFERENTIATED. A NON-COMEDO INTRADUCTAL CARCINOMA COMPONENT IS IDENTIFIED, COMPRISING. LESS THAN 10% OF THE CARCINOMA. NO TUMOR IS SEEN IN THE DEEP SURGICAL MARGIN. 1 of 2. NO VASCULAR INVASION IS IDENTIFIED. TWO OF SEVENTEEN (2/17) LYMPH NODES ARE POSITIVE FOR METASTATIC. ADENOCARCINOMA. BREAST TISSUE WITH APOCRINE METAPLASIA AND MICROCALCIFICATIONS IN. NON-NEOPLASTIC LOBULES. 2 of 2.","The patient underwent a right modified radical mastectomy for a right breast cancer, with a clinical history of a right breast cancer and a concern for a deep margin positive result. The microscopic examination revealed a tumor consisting of tubules and cribriform glands composed of atypical cells with a moderate amount of eosinophilic cytoplasm and oval nuclei with distinct relatively small nucleoli. The tumor was diagnosed as infiltrating ductal carcinoma, measuring 2.5 cm, with a histologic grade of II/III and nuclear grade moderately differentiated. A non-comedo intraductal carcinoma component was identified, comprising less than 10% of the carcinoma. The deep surgical margin was negative for tumor. Vascular invasion was not identified, but two of seventeen lymph nodes were positive for metastatic adenocarcinoma. Additional findings included breast tissue with apocrine metaplasia and microcalcifications in non-neoplastic lobules.","The patient underwent a right modified radical mastectomy for a right breast cancer, with a clinical history of a right breast cancer and a concern for a deep margin positive result. The microscopic examination revealed a tumor consisting of tubules and cribriform glands composed of atypical cells with a moderate amount of eosinophilic cytoplasm and oval nuclei with distinct relatively small nucleoli. The tumor was diagnosed as infiltrating ductal carcinoma, measuring 2.5 cm, with a histologic grade of II/III and nuclear grade moderately differentiated. A non-comedo intraductal carcinoma component was identified, comprising less than 10% of the carcinoma. The deep surgical margin was negative for tumor. Vascular invasion was not identified, but two of seventeen lymph nodes were positive for metastatic adenocarcinoma. Additional findings included breast tissue with apocrine metaplasia and microcalcifications in non-neoplastic lobules."
TCGA-2Y-A9H1,TCGA-2Y-A9H1.04B342FC-F63A-4C81-BFF7-556C0424BF97,"Final Diagnosis. A. LIVER, LEFT LATERAL SEGMENT, SEGMENTECTOMY: Hepatocellular carcinoma, see Key Pathological Findings. I,. the attending pathologist, personally reviewed the. entire case and rendered the final diagnosis. Electronically signed out by. Ancillary Studies. Immunohistochemistry stains were prformed with adequate controis on block A4 and revealed the. tumor cells to be positive for AFP, Hep-par1, CEA-p (canalicular pattern), CK7 and CK20. Special stains Trichrome, reticulin, and iron were performed with adequate controls on block A5 and. showed portal fibrosis with short fibrous septa and no excess iron. Key Pathological Findings. A: Liver, Resection, Synoptic Data. SPECIMEN TYPE: Left lateral segmentectomy. FOCALITY: Solitary (specify location): left lateral segment. TUMOR SIZE: 3.1 cm. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: Gll: Moderately differentiated. PRIMARY TUMOR (pT): pT1: Solitary tumor with no vascular invasion. REGIONAL LYMPH NODES (pN): pNX: Cannot be assessed. DISTANT METASTASIS (pM): pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 9 mm. VENOUS (LARGE VESSEL) INVASION (V): Absent. ADDITIONAL PATHOLOGIC FINDINGS: Other (specify): fibrous expansion of some portal areas with short fibrous septa (modified. Ishak stage 1 ). Specimen(s) Received. A. LEFT LATERAL SEGMENT OF LIVER FS. Clinical History. LIVER CA. HCC. Preoperative Diagnosis. Liver cancer, HCC. Frozen Section Diagnosis. FSA1. LEFT LATERAL SEGMENT OF LIVER: Approximately 3.5 cm nodule at least 1 cm from all margins. Comment: This frozen section diagnosis/result was communicated to and acknowledged by. in. at. I,. have performed the intraoperative consultation and issued the above diagnosis. Gross Description. A. The specimen is received fresh labeled ""left lateral segment of liver"" and consists of a. previously incised. 138 gram, 11.9 x 7.8 x 4.2 cm wedge of liver with numerous staples at the. resection margin. The capsule is smooth, purple red with a 2.7 cm subcapsular nodule. Sectioning. reveals a 3.1 x 2.6 x 2.2 cm, tan yellow nodule which extends 1.1 cm from the parenchymal margin up. to the overlying capsule. The surrounding parenchyma is dense, tan brown and mildly indurated. The. parenchymal margin is inked blue, the specimen is serially sectioned and representative sections are. submitted as labeled: A1-A3: Tumor to parenchymal margin. A4-A5: Tumor to adjacent parenchyma and capsule. A7: Vascular margins. A8: Normal-appearing parenchyma. Tissue is submitted to Tissue Procurement Laboratory.","The patient underwent a left lateral segmentectomy for a liver mass. The tumor was a 3.1 cm hepatocellular carcinoma, moderately differentiated, with no vascular invasion. The tumor was solitary and located in the left lateral segment, with a clear margin of 9 mm from the closest resection margin. Immunohistochemistry stains revealed the tumor cells to be positive for AFP, Hep-par1, CEA-p (canalicular pattern), CK7, and CK20. Special stains showed portal fibrosis with short fibrous septa and no excess iron. The tumor was staged as pT1 with no lymph node involvement (pNX) or distant metastasis (pMX). The liver tissue showed fibrous expansion of some portal areas with short fibrous septa, classified as modified Ishak stage 1.","The patient underwent a left lateral segmentectomy. The tumor was a 3.1 cm hepatocellular carcinoma, moderately differentiated, with no vascular invasion. The tumor was solitary and located in the left lateral segment, with a clear margin of 9 mm from the closest resection margin. Immunohistochemistry stains revealed the tumor cells to be positive for AFP, Hep-par1, CEA-p (canalicular pattern), CK7, and CK20. Special stains showed portal fibrosis with short fibrous septa and no excess iron. The tumor was staged as pT1. Lymph node involvement and distant metastasis could not be assessed (pNX and pMX). The liver tissue showed fibrous expansion of some portal areas with short fibrous septa, classified as modified Ishak stage 1."
TCGA-GV-A3JZ,TCGA-GV-A3JZ.A1CF42EF-92A6-4214-BB25-7C71F665EFDC,"De-Identified Specimen Code. / M. SPECIMEN SUBMITTED: Part A: LEFT DISTAL URETER. Part B: LEFT PELVIC LYMPH NODE. Part C: RIGHT DISTAL URETER. Part D: FINAL URETHRAL MARGIN. Part E: BLADDER AND PROSTATE. Part F: LEFT DISTAL URETER #2. Part G: RIGHT PELVIC LYMPH NODES. Part H: RIGHT COMMON LYMPH NODES. Part I: LEFT COMMON LYMPH NODES. Part J: LEFT PELVIC LYMPH NODES. Part K: PRESACRAL LYMPH NODES. Final Diagnosis. 1. Left distal ureter, biopsy (A) - Atypical urothelial cells. 2. Left pelvic lymph nodes, excision (B) - Metastatic urothelial carcinoma involving one lymph node. 3. Right distal ureter and final urethral margin, biopsies (C, D) - Negative for neoplasm. 4. Bladder, excision (E) - Invasive poorly differentiated urothelial carcinoma with invasion through. muscular wall and involvement of perivesical adipose tissue. 5. Prostate, excision (E) - Urothelial carcinoma involving prostatic urethra with invasion into. adjacent prostatic parenchyma. 6. Left distal ureter #2, biopsy (F) - Negative for neoplasm. 7. Right pelvic lymph nodes, excision (G) - Negative for neoplasm, fourteen lymph nodes. 8. Right common lymph nodes, excision (H) - Negative for neoplasm, nine lymph nodes. 9. Left common lymph nodes, excision (I) - Metastatic urothelial carcinoma involving two of six. lymph nodes. 10. Left common lymph nodes, excision (J) - Metastatic urothelial carcinoma involving two of four. lymph nodes. 11. Presacral lymph nodes, excision (K) - Negative for neoplasm, five lymph nodes. Diagnosis Comment: 2. The carcinoma was only present in the permanent section and not present in the frozen section. 4. Specimen Type: Radical cystoprostatectomy. Tumor Size, Greatest dimension: 3.5 cm. Histologic Type: Urothelial carcinoma. Urothelial Carcinoma: (WHO/ISUP, 1998): High grade. Adenocarcinoma and Squamous Carcinoma: Not applicable. Associated Epithelial Lesions: None identified. Margins: Margins uninvolved by invasive carcinoma. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Present. Direct Extension of Invasive Tumor: Perivesical fat. Prostatic stroma. Other Diagnoses: See above. Pathologic Stage: Primary Tumor: (pT). pT4a: Tumor invades prostate. Regional Lymph Nodes: (pN). pN3: Metastasis in common iliac lymph nodes The size of the largest metastasis is 2.2 cm. The tumor. extends beyond the lymph node capsules to involve the adjacent adipose tissue. Distant Metastasis (pM): pMX: Cannot be assessed. Clinical Diagnosis: BLADDER CA. Gross Description: A. Received fresh at the frozen desk is a specimen labeled ""left distal ureter"" consisting of one piece of. unoriented renal tissue measuring 0.8 x 0.6 X 0.3 cm. The specimen is totally submitted for frozen. section as A1. B. Received fresh at the frozen desk is a specimen labeled ""left pelvic lymph node"" consisting of one. ovoid nodule measuring 1.5 x 1 X 0.5 cm. The specimen is totally submitted for frozen section as B1. C. Received fresh at the frozen desk is a specimen labeled ""right distal ureter"" consisting of one piece. of unoriented luminal tissue measuring 0.7 x 0.7 x 0.3 cm. The specimen is totally submitted for frozen. section as C1. D. Received fresh at the frozen desk is a specimen labeled ""final urethral margin"" consisting of one. piece of unoriented tissue measuring 0.5 x 0.5 x 0.5 cm. The specimen is totally submitted for frozen. section in D1. E. Received in formalin previously opened and inked with the margins taken is a specimen which. consists of a urinary bladder, bilateral ureters, prostate and attached seminal vesicles and vas deferens. The bladder measures 13.0 x 9.0 x 5.5 cm. The external surface of the bladder is covered by a serosal. lining at the dome and fibroadipose tissue at the remaining portion. After the bladder is opened an. irregular, tan-white, firm area is identified measuring 3.5 x 3.0 cm. The mass appears to encompass the. entire trigone, the anterior, posterior, left bladder walls and both ureteral orifices. The mass is semisolid. with tan-brown to white, friable possible papillary areas. On sectioning, the mass appears to extend. through the left wall for a distance of 1.5 cm and is 0.2 cm from the soft tissue line of resection (inked. black). It does not appear to involve the perivesicular adipose tissue. Purulent material is present upon. sectioning of the left wall and left trigone. The remainder of the bladder wall appears edematous and. diffusely hemorrhagic. The hemorrhagic areas are predominantly visible on the posterior bladder wall. A. 3.0 cm segment of right ureter is present. It is probe patent. Its mucosa is slightly inflamed and. granular. A 2.0 cm segment of left ureter is present. It is probe patent and its mucosa is inflamed and. granular. The prostate measures 3.0 cm anteroposteriorly, 3.2 cm craniocaudally, and 4.0 cm. transversely. The capsular surface appears slightly roughened but complete. The gland is inked blue on. the right and yellow on the left, and sectioned from the apex to base transversely at 3 mm intervals. perpendicular to the urethra. The cross sections reveal a yellow-tan mottled cut surface. A definitive. mass is not identified. Rubbery nodularity is present. The seminal vesicles appear unremarkable. Segments of vas deferens appear unremarkable. Sectioning of the attached fibroadipose tissue reveals. three tan-white firm nodules, resembling lymph nodes ranging in size from 0.3-0.6 cm in greatest. dimension. Representative sections are submitted in formalin as follows: E1 right distal ureter shave,. E2 left distal ureter shave, E3-E4 anterior bladder wall, E5 left wall to include deepest extent of lesion,. E6 left ureteral orifice, E7-E8 left trigone, E9 posterior wall demonstrating hemorrhagic mucosa, E10. dome demonstrating hemorrhagic mucosa, E11 right ureteral orifice, E12 right wall, E13 right trigone,. E14 right ureteral mucosa (1.0 cm from distal margin), E15 left ureter mucosa (1.2 cm from distal. margin), E16 lymph nodes (3), E17 right apex, E18 left apex, E19 3 mm right, E20 3 mm left, E21 15. mm right anterior (capsular surface incomplete), E22 15 mm right posterior to include seminal vesicles,. E23 left anterior (capsular surface incomplete), E24 15 mm left posterior to include seminal vesicles. Gross Description: F. Received fresh at the frozen desk is a specimen labeled ""left distal ureter #2"" consisting of one piece. of unoriented luminal tissue measuring 1 x 0.5 x 0.5 cm. The specimen is totally submitted for frozen. section in F1. G. Received in formalin labeled ""right pelvic lymph nodes"" is a specimen consisting of multiple. fragments of fibrofatty tissue aggregating to 7 x 5 x 1.7 cm. On sectioning, 14 possible lymph nodes. are identified ranging in diameter from 0.2 to 1 cm. Sections are submitted as follows: G1 five possible. lymph nodes, G2 four possible lymph nodes, G3 four possible lymph nodes, G4 one possible lymph. node bisected. H. Received in formalin labeled ""right common lymph nodes"" is a specimen consisting of multiple. fragments of fibrofatty tissue aggregating to 3 x 2 x 1 cm. Nine possible lymph nodes are identified. ranging in diameter from 0.2 to 1.5 cm. Sections are submitted as follows: H1 four possible lymph. nodes, H2 four possible lymph nodes, H3 one possible lymph node sectioned and totally submitted. I. Received in formalin labeled ""left common lymph node"" is a specimen consisting of multiple. fragments of fibrofatty tissue aggregating to 9 x 4 x 2 cm. Four possible tan lymph nodes are identified,. two large lymph nodes measuring 3 and 4.5 cm in diameter. Sections are submitted as follows: 11 four. possible lymph nodes, 12-14 one lymph node sectioned and totally submitted, 15-18 one lymph node. sectioned and totally submitted. J. Received in formalin labeled ""left pelvic lymph nodes"" is a specimen consisting of multiple fragments. of fibrofatty tissue aggregating to 6 x 2.5 x 1.5 cm. Three possible lymph nodes are identified ranging in. diameter from 0.5 to 3 cm. Also present is an elongated firm cord-like structure measuring 5 x 0.5 x 0.4. cm. Sections are submitted as follows: J1 one lymph node sectioned and totally submitted, J2 one. lymph node, J3 cord-like structure sectioned and totally submitted, J4-J5 one lymph node sectioned. and totally submitted. K. Received in formalin labeled ""presacral lymph nodes"" is a specimen consisting of multiple fragments. of fibrofatty tissue aggregating to 3.5 X 2.5 X 0.5 cm. Five possible lymph nodes are identified ranging in. diameter from 0.1 to 0.6 cm. The five possible lymph nodes are submitted in K1.","The pathology report reveals the following results: 

The left distal ureter biopsy (A) shows atypical urothelial cells. The left pelvic lymph nodes (B) show metastatic urothelial carcinoma involving one lymph node. The right distal ureter and final urethral margin biopsies (C, D) are negative for neoplasm. The bladder and prostate excision (E) shows invasive poorly differentiated urothelial carcinoma with invasion through the muscular wall and involvement of perivesical adipose tissue. The urothelial carcinoma involves the prostatic urethra with invasion into adjacent prostatic parenchyma. The left distal ureter #2 biopsy (F) is negative for neoplasm. The right pelvic lymph nodes (G) are negative for neoplasm, with 14 lymph nodes examined. The right common lymph nodes (H) are negative for neoplasm, with 9 lymph nodes examined. The left common lymph nodes (I) show metastatic urothelial carcinoma involving 2 of 6 lymph nodes. The left common lymph nodes (J) show metastatic urothelial carcinoma involving 2 of 4 lymph nodes. The presacral lymph nodes (K) are negative for neoplasm, with 5 lymph nodes examined. Microscopic description of the bladder and prostate excision (E) shows a high-grade urothelial carcinoma with invasion through the muscular wall and involvement of perivesical adipose tissue, and the tumor extends beyond the lymph node capsules to involve the adjacent adipose tissue. The tumor size is 3.5 cm, and the largest metastasis is 2.2 cm. The clinical diagnosis is bladder cancer.","The pathology report reveals the following results: The left distal ureter biopsy (A) shows atypical urothelial cells. The left pelvic lymph nodes (B) show metastatic urothelial carcinoma involving one lymph node. The right distal ureter and final urethral margin biopsies (C, D) are negative for neoplasm. The bladder and prostate excision (E) shows invasive poorly differentiated urothelial carcinoma with invasion through the muscular wall and involvement of perivesical adipose tissue. The urothelial carcinoma involves the prostatic urethra with invasion into adjacent prostatic parenchyma. The left distal ureter #2 biopsy (F) is negative for neoplasm. The right pelvic lymph nodes (G) are negative for neoplasm, with 14 lymph nodes examined. The right common lymph nodes (H) are negative for neoplasm, with 9 lymph nodes examined. The left common lymph nodes (I) show metastatic urothelial carcinoma involving 2 of 6 lymph nodes. The left common lymph nodes (J) show metastatic urothelial carcinoma involving 2 of 4 lymph nodes. The presacral lymph nodes (K) are negative for neoplasm, with 5 lymph nodes examined. Microscopic description of the tumor shows a high-grade urothelial carcinoma with invasion through the muscular wall and involvement of perivesical adipose tissue. In lymph node metastases, the tumor extends beyond the lymph node capsules to involve the adjacent adipose tissue. The tumor size is 3.5 cm, and the largest metastasis is 2.2 cm. The clinical diagnosis is bladder cancer."
TCGA-BH-A208,TCGA-BH-A208.4F943D12-E769-45F3-86BE-75193786DD4E,"DIABNOSIS: 16 H&E STAINED SLIDES. PREVIOUS REPORTS: SPECIMEN DATE: LEFT MASTECTOMY: NEILTRATING DUCTAL CARCINOMA, NOT OTHERWISE SPECIFIED. 6.0. RY 2.0 BY 270 CM.. POORLY DIFFERENTIATED INTERMEDIATE. NUCLEAR GRADE EXTENDING TO WITHIN 1 MM OF LINE OF RESECTION. AND MASSIVE VASCULAR PERMEATION, INCLUDING NIPPLE. FIBROCYSTIC CHANGES. THREE OF FIFTEEN: (3/15) AXILLARY LYMPH NODES POSITIVE FOR. METASTATIC TUMOR WITH CAPSULAR AND EXTRACAPSULAR EXTENSION.","The pathology report reveals a diagnosis of poorly differentiated intermediate nuclear grade invasive ductal carcinoma, not otherwise specified, measuring 6.0 cm in size with a 2.0 cm margin. Microscopic examination of the slides shows the tumor extending within 1 mm of the line of resection and massive vascular permeation, including the nipple. Fibracyclic changes were also observed. Additionally, 3 out of 15 axillary lymph nodes were positive for metastatic tumor with capsular and extracapsular extension.","The pathology report reveals a diagnosis of poorly differentiated intermediate nuclear grade invasive ductal carcinoma, not otherwise specified. Microscopic examination of the slides shows the tumor extending within 1 mm of the line of resection and massive vascular permeation, including the nipple. Fibrocystic changes were also observed. Additionally, 3 out of 15 axillary lymph nodes were positive for metastatic tumor with capsular and extracapsular extension."
TCGA-BF-A3DJ,TCGA-BF-A3DJ.BF41787D-E227-4BD0-A090-A6A44B5763E0,Sex: Female. Diagnosis: Melanoma Histological description: Melanoma. Anatomic Site: Skin Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: Frozen. Container: cryomold Type of Procurement: Surgery Grade: 3. T Stage: 4b N Stage: 1 M Stage: 0 Treatment: no. Treatment Details: no/no. Normal Sample. Anatomic Site: Blood Sample Type: normal Type of Procurement: Blood draw. Matrix: Blood Specimen Format: Frozen Container: tube.,"The patient is a female with a diagnosis of melanoma, specifically a primary skin tumor. Microscopic examination revealed melanoma. The tumor is classified as grade 3. The cancer has spread to the lymph nodes (N1) but not to distant sites (M0), indicating a T4b stage.","The patient is a female with a diagnosis of melanoma, specifically a primary skin tumor. Microscopic examination revealed melanoma. The tumor is classified as grade 3. The cancer is stage T4b and has spread to the lymph nodes (N1) but not to distant sites (M0)."
TCGA-BP-5184,TCGA-BP-5184.2e8c6858-5b76-416c-bc73-ec8359565e0c,"Clinical Diagnosis & History: Left renal mass, left partial nephrectomy. Specimens Submitted: 1: KIDNEY, LEFT HILAR, TUMOR, PARTIAL NEPHRECTOMY. DIAGNOSIS: 1. KIDNEY, LEFT HILAR, TUMOR, PARTIAL NEPHRECTOMY: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 3.3 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh for frozen section consultation and is labeled ""Left renal hilar tumor, stitch marks deep surgical. margin"". It consists of a 3.7 X 2.8 x 2.4 cm wedge shaped portion of kidney with a suture marking the deep margin. The margin is. inked black and the specimen is serially sectioned to reveal a yellow hemorrhagic mass measuring 3.3 x 2.6 X 2,3cm. The. clearance from the resection margin is abutting the inked margin, A representative section of the nearest margin is submitted for. frozen section diagnosis. Representatively submitted, Portions of the tumor are submitted for TPS. Summary of sections: FSC - frozen section control. T tumor. M margin. RS - representative sections. Summary of Sections: Part 1: KIDNEY, LEFT HILAR, TUMOR, PARTIAL NEPHRECTOMY. Block. Sect. Site. PCs. 1. FSC. 1. 1. M. 1. RS. 1. 1. T. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: AREA AT STITCH NEGATIVE FOR TUMOR. RENAL CELL CARCINOMA. PERMANENT DIAGNOS(S: SAME.","The pathology report indicates a diagnosis of renal cell carcinoma, conventional (clear cell) type, with a Fuhrman nuclear grade of III/IV. The tumor measures 3.3 cm in greatest diameter and is limited to the kidney. There is no local invasion, renal vein invasion, or lymph node involvement. The surgical margins are free of tumor, and the non-neoplastic kidney tissue is unremarkable. Microscopically, the tumor is described as a yellow hemorrhagic mass with a clear clearance from the resection margin. The frozen section diagnosis was confirmed by permanent sections, showing renal cell carcinoma.","The pathology report indicates a diagnosis of renal cell carcinoma, conventional (clear cell) type, with a Fuhrman nuclear grade of III/IV. The tumor measures 3.3 cm in greatest diameter and is limited to the kidney. There is no local invasion, renal vein invasion, or lymph node involvement. The surgical margins are free of tumor, and the non-neoplastic kidney tissue is unremarkable. The frozen section diagnosis was confirmed by permanent sections, showing renal cell carcinoma."
TCGA-ZH-A8Y8,TCGA-ZH-A8Y8.D35938C2-CFED-444E-8284-B1A4D5EAD0F3,"SURGICAL. PATHOLOGY Site Intrahepatic bile duet. Diagnosis. A: Lymph node, hepatoduodenal, biopsy. - One benign lymph node, negative for metastatic carcinoma (0/1). B: Liver, left lobe, partial hepatectomy. Histologic tumor type/subtype: cholangiocarcinoma (see comment). Histologic grade: moderately differentiated. Tumor location: left lobe. Tumor size: 3.9 cm (gross measurement). Focality: unifocal. Tumor growth pattern: mass forming. Tumor necrosis/treatment effect: scattered associated tumor necrosis. present (no known prior treatment). Vascular invasion: not identified. Perineural invasion: focally present. Capsular invasion: not identified. Margins: parenchymal margin is uninvolved by tumor, 2.1 cm away. Lymph nodes: see specimen A. Background liver : scattered mild chronic inflammation, minimal. microvesicular steatosis involving less than 5% of the hepatic. parenchyma, and mildly increased portal fibrosis. AJCC Pathologic TNM Stage: pT1 pNO. NOTE: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Comment: Based on the lack of clinical or radiologic evidence to support the. presence of a primary adenocarcinoma arising outside of the liver,. the presence of a 3.9 cm solitary mass in the left liver lobe. consisting of moderately differentiated adenocarcinoma is consistent. with a diagnosis of cholangiocarcinoma. Special stains are performed on a section of liver parenchyma away. from the tumor mass. The liver is negative for significant iron. deposition. There is no evidence of alpha-1-antitrypsin deficiency. (no DPAS positive globules identified within hepatocytes) . A. trichrome stain shows a mild increase in portal fibrosis. A. reticulin stain also highlights the mild increase in fibrosis with. an otherwise normal hepatic plate thickness. Intraoperative Consult Diagnosis: A frozen section consultation was requested by Dr. in OR. Specimen delivery time is. FSA1: Lymph node, hepatoduodenal, biopsy. - No tumor seen. Moderate number of MN giant cells, histiocytosis. Drs. on. at. Frozen Section Pathologist: , MD. Clinical History : -year-olo male with a liver adenocarcinoma favoring. cholangiocarcinoma, questionable primary upper GI or biliary tree. Gross Description: Received are two appropriately labeled containers. Specimen A is. received fresh for frozen section. Container A is additionally labeled ""hepatoduodenal lymph node for. frozen section. "" It consist of a 2.2 X 2.0 X 1.0 cm green/brown. lymph node candidate. The specimen is serially sectioned and. entirely submitted for frozen section and resubmitted in block FSA1. and FSA2,. Container B: Specimen Type: left lobectomy. Specimen Weight: 355 grams. Measurement: 15.0 X 14.4 X 3.5 cm. Orientation: The specimen is received with a stitch marking the. caudal cut margin. The surgical cut margin is inked blue. Capsule: red/brown and smooth. Mass: 3.9 X 3.5 X 2.2 cm; The mass is within the specimen; it is. near the falciform ligament. The mass is tan/white and firm with. relatively circumscribed edges. Distance from the capsule: 0.5 cm. Distance from the inked surgical margin: 2.2 cm; no necrosis is seen. Adjacent liver tissue: tan/brown, firm and unremarkable. Major portal vein/ hepatic vein: n/a. Gallbladder: n/a. Other comments: Tissue and normal tissue to Tissue Procurement. Block Summary: B1 - ductal structures, en face. B2 - mass with respect to capsule. B3 - mass with respect to surgical margin, bisected. B4, B5 - sections of tumor with respect to bile duct. B6 - normal liver parenchyma. Tissue remains.","The patient is a year-old male with a liver adenocarcinoma favoring cholangiocarcinoma, questionable primary upper GI or biliary tree. The histologic tumor type/subtype is cholangiocarcinoma, moderately differentiated, located in the left lobe, measuring 3.9 cm, unifocal, mass-forming, with scattered associated tumor necrosis, and focally present perineural invasion. The tumor is 2.1 cm away from the parenchymal margin and 2.2 cm away from the inked surgical margin. The lymph nodes are negative for metastatic carcinoma. The background liver shows scattered mild chronic inflammation, minimal microvesicular steatosis involving less than 5% of the hepatic parenchyma, and mildly increased portal fibrosis. The AJCC Pathologic TNM Stage is pT1 pNO. Special stains are negative for significant iron deposition, alpha-1-antitrypsin deficiency, and no evidence of DPAS positive globules within hepatocytes. A trichrome stain shows a mild increase in portal fibrosis, and a reticulin stain highlights the mild increase in fibrosis with an otherwise normal hepatic plate thickness.","The patient is male with a liver adenocarcinoma favoring cholangiocarcinoma, questionable primary upper GI or biliary tree. The histologic tumor type/subtype is cholangiocarcinoma, moderately differentiated, located in the left lobe, measuring 3.9 cm, unifocal, mass-forming, with scattered associated tumor necrosis, and focally present perineural invasion. The tumor is 2.1 cm away from the parenchymal margin and 2.2 cm away from the inked surgical margin. The lymph nodes are negative for metastatic carcinoma. The background liver shows scattered mild chronic inflammation, minimal microvesicular steatosis involving less than 5% of the hepatic parenchyma, and mildly increased portal fibrosis. The AJCC Pathologic TNM Stage is pT1 pN0. Special stains are negative for significant iron deposition, alpha-1-antitrypsin deficiency (no evidence of DPAS positive globules within hepatocytes). A trichrome stain shows a mild increase in portal fibrosis, and a reticulin stain highlights the mild increase in fibrosis with an otherwise normal hepatic plate thickness."
TCGA-HZ-A77P,TCGA-HZ-A77P.71CF594D-2A24-4B98-AF3F-1D97DF421433,"Gender: M. Provider Group : Date of Service: Date Received: A copy of this report will be faxed to: FINAL SURGICAL PATHOLOGY REPORT Adenoracinone) NOS. Diagnosis: A. GALLBLADDER, CHOLECYSTECTOMY: - MILD CHRONIC CHOLECYSTITIS,. - ONE REACTIVE LYMPH NODE, NO TUMOR SEEN (0/1). B. LYMPH NODE, BILE DUCT, EXCISION: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. STOMACH, DUODENUM, PANCREAS, WHIPPLE PROCEDURE: - ADENOCARCINOMA, WELL DIFFERENTIATED. - TUMOR SIZE 3.1 CM. TUMOR INVADES TO PERIPANCREATIC SOFT TISSUE AND INTO. MUSCULARIS PROPRIA OF DUODENUM. - SURGICAL MARGINS NEGATIVE. ONE OF TWENTY LYMPH NODES POSITIVE FOR METASTATIC. CARCINOMA (1/20). - LYMPHOVASCULAR INVASION PRESENT. PATHOLOGIC TUMOR STAGING SYNOPSIS (PANCREAS): Type and grade: Adenocarcinoma, well differentiated. Primary tumor: pT3. Regional lymph node: pN1. Distant metastasis: N/A. Pathologic stage: IIB. Lymphovascular invasion: Present. Margin status: R0, negative. Tumor Staging Information. Data derived from current specimen. Staging in accordance with or modified from AJCC Cancer Staging. FINAL SURGICAL PATHOLOGY REPORT. Handbook, 7th Ed, and CAP protocol, June 2012. Specimen: Stomach, duodenum, pancreas. Procedure: Whipple excision. Tumor site: Head of pancreas. Tumor size: 3.1 cm. Histologic type: Adenocarcinoma,. Histologic grade: G1, well differentiated. Microscopic tumor extension: Tumor extends to peripancreatic soft ussue and. muscularis propria of duodenum. MARGINS: R0, negative, closest margin deep at 0,5 cm, common. bile duct and pancreatic margin >2 cm. Treatment effect: N/A. Lymphovascular invasion: Present. Perineural invasion: Not identified. LYMPH NODES;. One of twenty lymph nodes positive for carcinoma. (1/20). PATHOLOGIC TUMOR STAGING: Primary tumor: Regiona lymph node: pN1. Distant metastasis: N/A. Pathologic stage: IIB. Source of Specimen: A. Gallbladder. B. Lymph node;Common bile duct lymph node. C. Whipple. Clinical History/Operative Dx: Malignant neoplasm of pancreas. Intraoperative Diagnosis: Pancreatic margin - no tumor seen; bile duct - no bile duct tissue identified in frozen. section. The intraoperative interpretation(s) was/were performed and rendered at. Gross Description: A. Part A designated gallbladder. Received in formalin is a previously disrupted, deflated gallbladder, 7.8. x 3.2x 1.2 cm. The serosa is glistening, fatty pink and tan. There are two paracystic duct lymph node. candidates are 0.3 and 0.4 cm each. The cystic duct margin demonstrates a narrow 1 mm lumen, difficult. to probe for patency, however, upon sectioning does not appear obstructed. The lumen contains a. residual amount of viscous dark green bile without calculi; no calcull are present within the container. The. mucosa is velvety, dark green with few raised yellow flecks without grossly unusual areas of change. suggestive of neoplasia. Representative sections are submitted for microscopic evaluation, including. representation of the cystic duct margin (orange), lymph node, mid fundus and dome of fundus in A1. B. Part 8 designated common bile duct lymph node. Received In formalin is a rubbery pink and tan lymph. node candidate measuring 1.1 x 0.6 x 0,5 cm. The lymph node and surrounding fat is now bisected and. submitted together in B1. This report continues (FINAL). Printed: C. Part C designated Whipple procedure. Initially received in a fresh state for frozen section analysis is a. generous portion of tissue, consistent with a Whipple procedure specimen. Il consists of a distal portion of. the antrum of the stomach, 12.0 cm along the greater curvature and 7.8 cm on the lesser, and up to 7.0. cm in diameter at the proximal surgical margin of resection; the small bowel is 21.0 cm in length with an. average diameter of 2.5 cm and up to 3.1 cm at the proximity of the pancreatic head; the pancreas. includes the head and portion of the body 5.7 cm in length, 5.0 cm Inferior-superlor, 4.2 cm. anterior-posterior. The common bile duct is obscurred by peripancreatic fat, and extends out to 1.8 cm, is. markedly narrow, 0.35 cm diameter. The CBD probe patent to a depth of 2.5 cm. FINAL SURGICAL PATHOLOGY REPORT. The gastric and small bowel is now opened, and examination of the small bowel demonstrates prominent,. semi-congested pink and tan circular plica, with the apparent ampulla of Vater oriented 6,4 cm distal to. the pylorus, and Is obscured by a ralsed, dusky red lesion measuring 1.3 x 0.8 cm. The AV through the. pancreatic duct is probe patent. Several attempts to probe the AV with the common bile duct is. unsuccessful. The CBD and distal pancreatic margin are submitted for frozen section analysis, the residual. frozen tissue submilled en face for permanent sections. The pancreas is initially bisected through the. ampulla of Vater. towards the distal margin, revealing a poorly demarcated, dense, pink-gray tumor mass. measuring upwards of 3.1 x 3.0 x 2.2 cm, and grossly approaching within 2.8 cm of the distal margin of. the pancreas, and 2.8 cm from the common bile duct margin and grossly approaching within 0.5 cm of the. pancreatic notch/adventitlal margin. The length of the common bile duct is opened, revealing a light pink. and tan mucosa that is roughly kinked within the head of the pancreas, and routes parallel to the. pancreatic duct and inserts 0.3 cm from the pancreatic duct into the ""ampulia of Vater"". The tumor mass. approaches wilhin 0.5 cm of the edge of the CBD. The tumor is primarily oriented within the head of the. pancreas with discrete contiguous relationship with the ampulla of Vater. In addition, 2.0 cm proximal to the ampulla of Vater, the small bowel demonstrates a distincily raised,. granular area of density, that upon sectioning reveals evidence of an accessory duct with associated. firmness suspicious for tumor (C7-C8). The area appears to grossly approach within 0.5 cm of the superior. edge of the radial surface. 1.0 cm of the posterior surface. 0.3 cm of the Inferior surface, and 0.7 cm of the. anterior surface. The surrounding pancreatic parenchyma is admixed fatly and glandular, pink and tan. No additional tesions are appreciated along the small bowel length, however, the pyloric ridge. demonstrates raised granular changes. The gastric mucosa is wrinkled, erythematous light pink and tan,. however, abruptly transitions to severely congested, deep red-brown throughout the proximal two-thirds of. the gastric antrum. No additional lesions appreciated. Initial examination of the peripancreatic fat reveals twenty additional lymph nodes ranging from 0.2 cm. 1.4 x 0.8 x 0.8 cm each. Examination of the lesser and greater gastric fat does not reveal gross lymph. node content. The lymph nodes are entirely submitted for microscopic evaluation, with the specimen. retained in. solution to enhance future lymph node, identification if Indicated. Cassette summary: C1) distal pancreatic surgical margin, FS,. C2) CBD margin, FS,. C3) additional CBD distal end,. C4) CBD and adjacent tumor relationship,. C5-C8) AV lesion. parallel CBD and pancreatic duct insertion relationship,. C7-C8) duodenal lesion, possible fused accessory duct - head of pancreas,. C9) tumor and pancreatic notch/adventitial margin relationship, possible lymph node,. C10) additional pancreatic notch margin, two pieces,. C11) pancreatic tumor, superior edge,. C12) tumor, posterior edge, including two lymph nodes,. C13) anterior pancreas, lengthwise sectloned, including distal edge of pancreatic duct, former margin. shaved for frozen section,. Printed: This report continues. FINAL SURGICAL PATHOLOGY REPORT. C14) inferior pancreas,. C15) most distal uncinate,. C16) proximal gastric margin of resection, anterior and posterior,. C17) distal smail bowel margin of resection, trimmed and submitted,. C18) gastric tissue, including pylorus,. C19) pylorus and distal length of smail bowel,. C20) small lymph nodes,. C21) six lymph nodes,. C22) single lymph node,. C23) two lymph nodes bisected, one marked orange,. C24) two lymph nodes bisected, one marked green,. C25) single lymph node bisected,. C26) single lymph node bisected,. C27) single lymph node trisected,. C28) largest lymph node trisected,. C29) peripancreatic fat possible lymph node or tumor content, adjacent ink surfaces, four pleces. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. An intradepartmental consultation with. was obtained. - Page 4. 1.","The patient is a male with a clinical history of a malignant neoplasm of the pancreas. The pathology report reveals a diagnosis of adenocarcinoma, well-differentiated, with a tumor size of 3.1 cm. The tumor invades the peripancreatic soft tissue and the muscularis propria of the duodenum. The surgical margins are negative, with one of twenty lymph nodes positive for metastatic carcinoma. Lymphovascular invasion is present. The pathologic tumor staging is pT3, pN1, and pathologic stage IIB. Microscopic examination of the tumor shows a poorly demarcated, dense, pink-gray tumor mass with a discrete contiguous relationship with the ampulla of Vater. The tumor approaches within 0.5 cm of the edge of the common bile duct. The surrounding pancreatic parenchyma is admixed with fatty and glandular, pink and tan tissue. No additional lesions are appreciated along the small bowel length, but the pyloric ridge demonstrates raised granular changes. The gastric mucosa is wrinkled, erythematous, light pink and tan, but abruptly transitions to severely congested, deep red-brown throughout the proximal two-thirds of the gastric antrum.","The patient is a male with a clinical history of a malignant neoplasm of the pancreas. The pathology report reveals a diagnosis of adenocarcinoma, well-differentiated, with a tumor size of 3.1 cm. The tumor invades the peripancreatic soft tissue and the muscularis propria of the duodenum. The surgical margins are negative, with one of twenty lymph nodes positive for metastatic carcinoma. Lymphovascular invasion is present. The pathologic tumor staging is pT3, pN1, and pathologic stage IIB. Microscopic examination of the tumor shows a poorly demarcated, dense, pink-gray tumor mass with a discrete contiguous relationship with the ampulla of Vater. The tumor approaches within 0.5 cm of the edge of the common bile duct. The surrounding pancreatic parenchyma is admixed with fatty and glandular, pink and tan tissue. No additional lesions are appreciated along the small bowel length, but the pyloric ridge demonstrates raised granular changes. The gastric mucosa is wrinkled, erythematous, light pink and tan, but abruptly transitions to severely congested, deep red-brown throughout the proximal two-thirds of the gastric antrum."
TCGA-A8-A07F,TCGA-A8-A07F.D1456192-83E7-4FC8-B783-90D615830156,"Diagnosis: 1. Ablated (left) breast sample with a moderately differentiated invasive ductal. carcinoma with an intraductal component (tumor diameter: 5.0 cm. Tumor classification: NOS, G II, pT2N1aLOVORO.","The patient's pathology report indicates a diagnosis of moderately differentiated invasive ductal carcinoma with an intraductal component in the left breast. The tumor measures 5.0 cm in diameter. Microscopic examination revealed a tumor classification of NOS (not otherwise specified) with a grade of G II, indicating moderate differentiation. The tumor is staged as pT2N1a, indicating a tumor size of 2 cm or more but not more than 5 cm, with lymph node involvement in one lymph node.","The patient's pathology report indicates a diagnosis of moderately differentiated invasive ductal carcinoma with an intraductal component in the left breast. The tumor measures 5.0 cm in diameter. Microscopic examination revealed a tumor classification of NOS (not otherwise specified) with a grade of G II, indicating moderate differentiation. The tumor is staged as pT2N1a, indicating a tumor size of 2 cm or more but not more than 5 cm, with lymph node involvement in one lymph node."
TCGA-BR-6458,TCGA-BR-6458.f8162f79-5a2d-4b69-877b-f7e796dc57b1,STOMACH TISSUE CHECKLIST. 11. Specimen type: Subtotal gastrectomy. Tumor site: Fundus. Tumor size: 0 X 0 X 8.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 1/15 positive for metastasis (Greater and lesser. omentum 1/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,"The pathology report reveals a subtotal gastrectomy specimen with a tumor located in the fundus, measuring 0 x 0 x 8.5 cm, and classified as an ulcerated, poorly differentiated adenocarcinoma. The tumor has extended to the subserosa. Lymph node metastasis was found in 1 out of 15 nodes, specifically in the greater and lesser omentum. Microscopic examination did not show lymphatic invasion, but venous invasion was absent. Perineural invasion was not specified. The tumor margins were uninvolved, and there was no evidence of neo-adjuvant treatment.","The pathology report reveals a subtotal gastrectomy specimen with a tumor located in the fundus, and classified as an ulcerated, poorly differentiated adenocarcinoma. The tumor has extended to the subserosa. Lymph node metastasis was found in 1 out of 15 nodes, specifically in the greater and lesser omentum. Venous invasion was absent. The tumor margins were uninvolved. Perineural invasion, lymphatic invasion, and evidence of neo-adjuvant treatment were not specified."
TCGA-4Z-AA83,TCGA-4Z-AA83.C177DD54-DBBB-44F1-9476-D5D1E543DE04,"PRIMARY SITE: Bladder. Product of cystectomy: Papillary urothelial carcinoma of high grade infiltrating the corion and focally the. detrusor muscle with free surgical margins. Absence of angiolymphatic, sanguineous and perineural invasions. Margin of right and left ureters free of neoplasia. Urethral margin free of neoplasia. Prostate free of cancer. Right and left seminal vesicles free of neoplasia. Right and left vas deferens free of neoplasia. Lymph nodes free of tumor: (0/2). Left pelvic lymph nodes: Absence of neoplasia: (0/13). Right pelvic lymph nodes: Absence of neoplasia: (0/4). External left iliac lymph nodes: Absence of neoplasia: (0/3). Right iliac lymph nodes: Absence of neoplasia: (0/6). Right common lymph nodes: Absence of neoplasia: (0/3).","The pathology report indicates a diagnosis of papillary urothelial carcinoma of high grade in the bladder, infiltrating the corion and focally the detrusor muscle with free surgical margins. Microscopic examination revealed no angiolymphatic, sanguineous, or perineural invasions. The margins of the right and left ureters, urethra, prostate, right and left seminal vesicles, and right and left vas deferens were all free of neoplasia. Lymph node examination showed no evidence of tumor in 2 right pelvic lymph nodes, 13 left pelvic lymph nodes, 3 external left iliac lymph nodes, 6 right iliac lymph nodes, and 3 right common lymph nodes.","The pathology report indicates a diagnosis of papillary urothelial carcinoma of high grade in the bladder, infiltrating the corion and focally the detrusor muscle with free surgical margins. Microscopic examination revealed no angiolymphatic, sanguineous, or perineural invasions. The margins of the right and left ureters, urethra, prostate, right and left seminal vesicles, and right and left vas deferens were all free of neoplasia. Lymph node examination showed no evidence of tumor in 4 right pelvic lymph nodes, 13 left pelvic lymph nodes, 3 external left iliac lymph nodes, 6 right iliac lymph nodes, and 3 right common lymph nodes."
TCGA-14-1795,TCGA-14-1795.1619def7-f24e-49cf-b2fb-1879951e0c62,"Document Date: Date Collected: Date Received: PT: DIAGNOSIS: 1. BRAIN, LEFT FRONTAL, BIOPSY, FS1A, TP1A: - GLIOBLASTOMA MULTIFORME. 2. BRAIN, LEFT FRONTAL, EXCISION: - GLIOBLASTOMA MULTIFORME. (nlectronic Signature). SPECIMEN: 1. Left frontal brain lesion. 2. Left frontal brain lesion. CLINICAL HISTORY/OPERATIVE FINDINGS: Left frontal brain lesion. Left frontal craniotomy for tumor resection. GROSS DESCRIPTION: Two specimens are received, the first fresh for intraoperative consultation,. and the second in formalin, each labeled with the patient's name and hospital. number. Specimen #1 is labeled as ""left frontal brain lesion. "" The specimen consists. of three pieces of soft pink tissue measuring in aggregate 1.0 x 0.8 X 0.4. A portionis-submitted for touch prep-evaluation. A representative. section is submitted for intraoperative consultation and frozen section. diagnosis, and the remainder of the cryoblock is submitted in cassette. ""FS1A. "" The remainder of the tissue is entirely submitted in cassette ""1B."". Specimen #2 is labeled as ""left frontal brain lesion."" The specimen consists. of multiple pieces of hemorrhagic brain tissue, the largest measuring 3.0 x. 2. X 1.5 cm, and the remaining pieces measuring 2.2 X 0.7 X 0.5 cm in. aggregate. Serial sectioning of the largest piece shows an irregular, poorly. circumscribed, yellow soft mass extending to the margins of resection. The. largest piece is inked blue prior to sectioning. The specimen is entirely. submitted in cassettes ""2A"" through ""2F."". INTRAOPERATIVE CONSULTATION: FS1A, TP1A: BRAIN, LEFT FRONTAL, BIOPSY (FROZEN SECTION, TOUCH PREPARATION) : GLIOBLASTOMA MULTIFORME. MICROSCOPIC DESCRIPTION: Microscopic examination performed. Medical Records. 1.","The patient underwent a left frontal craniotomy for tumor resection. The microscopic examination of the brain tissue revealed a diagnosis of glioblastoma multiforme in both the biopsy and excision specimens. The microscopic description showed an irregular, poorly circumscribed, yellow soft mass extending to the margins of resection. The tumor was identified as glioblastoma multiforme in the frozen section (FS1A, TP1A) and in the final microscopic examination.","The patient underwent a left frontal craniotomy for tumor resection. The microscopic examination of the brain tissue revealed a diagnosis of glioblastoma multiforme in both the biopsy and excision specimens. The microscopic description showed an irregular, poorly circumscribed, yellow soft mass extending to the margins of resection. The tumor was identified as glioblastoma multiforme in the frozen section (FS1A, TP1A) and in the final microscopic examination."
TCGA-AA-3841,TCGA-AA-3841.a7348faf-df79-4765-8910-b183a408e905,"Diagnosis: This material shows in I) parts of an invasive adenocarcinoma of the colon G2 with penetration. of all parietal layers (pT3, L1, V1) and with free lymph nodes,. in II) an additional adenocarcinoma, of moderate differentiation G2, with infiltration of the. muscularis (pT2, L1, V1), as well as a tubular adenoma and a lymph node metastasis, thus. corresponding to N1 (1 of 16). Tumor classification: I. ICDO-DA M-8140/3, G2, pT3, L1, V1, pNO (0 of 24). II. ICDO-DA M-8140/3, G2, pT2, L1, V1, pN1 (1 of 16).","The pathology report shows two separate adenocarcinomas of the colon, both of moderate differentiation (G2). The first adenocarcinoma is invasive, penetrating all parietal layers (pT3) with lymph node involvement (N1, 1 of 16). The second adenocarcinoma is also invasive, infiltrating the muscularis (pT2), with lymph node involvement (pN1, 1 of 16). Microscopic examination revealed tubular adenoma and lymph node metastasis.","The pathology report shows two separate adenocarcinomas of the colon, both of moderate differentiation (G2). The first adenocarcinoma is invasive, penetrating all parietal layers (pT3) with no lymph node involvement (pN0, 0 of 24). The second adenocarcinoma is also invasive, infiltrating the muscularis (pT2), with lymph node involvement (pN1, 1 of 16). Other findings included tubular adenoma."
TCGA-CN-6996,TCGA-CN-6996.0475c8e9-f3aa-418f-8685-ea32cd6b89c8,"Report Type. Date of Event. F. Authored by. Hosp/Group. Record Status. FINAL DIAGNOSIS: PART 1: RIGHT HEMIGLOSSECTOMY. A. INVASIVE SQUAMOUS CELL CARCINOMA (4.2 CM), MODERATELY. DIFFERENTIATED, KERATINIZING, INVOLVING INTRINSIC TONGUE MUSCLES. B. VASCULAR AND PERINEURAL INVASION IS PRESENT. C. ANTERIOR, POSTERIOR, AND DEEP TONGUE MARGINS ARE FREE OF. CARCINOMA. CARCINOMA EXTENDS TO ANTERIOR AND POSTERIOR FLOOR OF MOUTH MARGINS. (see parts 2-6 for final true margins). D. PATHOLOGIC STAGE: pT3 N2b. PART 2: ANTERIOR FLOOR OF MOUTH MARGIN, RE-RESECTION. NO TUMOR SEEN. PART 3: POSTERIOR FLOOR OF MOUTH MARGIN, RE-RESECTION. NO TUMOR SEEN. PART 4: MEDIAL POSTERIOR FLOOR OF MOUTH/TONGUE, BIOPSY. INVASIVE SQUAMOUS CELL CARCINOMA, BASED ON ORIGINAL FROZEN SECTION. SLIDES. PART 5: NEW POSTERIOR MARGIN. NO TUMOR SEEN. PART 6: DEEP MUSCLE MARGIN. NO TUMOR SEEN. PART 7: RIGHT NECK DISSECTION, LEVELS 1 THROUGH 4. A. METASTATIC SQUAMOUS CELL CARCINOMA, UP TO 3.5 CM, IN FIVE (5) OF. TWENTY-FOUR (24) LYMPH NODES (5/24), INVOLVING LEVELS 1A AND 2. B. EXTRANODAL EXTENSION IS PRESENT. C. VASCULAR INVASION IS PRESENT. By Pathologist: My signature is attestation that I have personally reviewed the submitted. material(s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in seven parts. Part 1 is received fixed labeled with the patient' S name, initials XXX and. ""right hemi-glossectomy."" It consists of a wedge of tan connective tissue,. 5.8 x 3.2 X 1.6 cm, partially covered with an ulcerated gray-white mucosa. Upon cross-sectioning, a 4.2 X 1.6 X 0.9 cm, white, firm lesion is identified. Digital image photographs are taken. Normal tissue and tissue from tumor were. banked for. Head and Neck Tissue Bank. Ink Code: Blue anterior margin. Green posterior margin. Black all other margins. Red banked area. Cassette Code: 1AFS anterior and posterior margin, shave. 1BFS anterior tongue margin, shave. 1CFS posterior tongue margin margin, shave. 1DFS anterior floor of mouth margin, shave. 1EFS posterior floor of mouth margin, shave. 1F-11 representative sections of the tumor. Part 2 is received fixed labeled with the patient' S name, initials XXX and. ""resection anterior floor of mouth.' It consists of a 2.4 X 1.0 X 0.8 cm, tan. connective tissue and gray-white mucosa. A suture marks medial margin (inked. black) and the true margin was identified by the surgeon (inked blue). After. frozen section analysis the specimen is submitted in cassette 2AFS. Part 3 is received fixed labeled with the patient' name, initials XXX and. ""resection posterior floor of mouth."" It consists of 1.0 X 0.5 x 0.6 cm of. tan connective tissue and gray-white mucosa. A suture marks posterior margin. (inked black) and the true margin was identified by the surgeon (inked blue). After frozen section analysis, the specimen is submitted in cassette 3AFS. Part 4 is received fixed labeled with the patient' name, initials XXX and. ""medial posterior floor of mouth/tongue."" It consists of 0.9 x 0.7 X 0.6 cm. of tan, connective tissue and mucosa. A suture marks posterior margin (inked. black) and the true margin was identified by the surgeon (inked blue). After. frozen section analysis, the specimen is submitted in cassette 4AFS. Part 5 is received fixed labeled with the patient' name, initials XXX and. ""new posterior margin."" It consists of 2.2 X 1.3 X 0.8 cm of tan, connective. tissue and mucosa. A suture marks posterior margin (inked black) and the true. margin was identified by the surgeon (inked blue). After frozen section. analysis the specimen is submitted in cassette 5AFS. Part 6 is received fixed labeled with the patient' name, initials XXX and. ""deep muscle margin."" It consists of 1.1 X 0.8 X 0.5 cm of tan, brown,. connective tissue specimen. After frozen section analysis, the specimen is. submitted in cassette 6AFS. Part 7 is received fixed, labeled with the patient's name, initials, XXX and. ""right neck dissection, levels 1-4"". It consists of a tan-yellow, elongated. fibroadipose tissue measuring 15.0 X 7.2 X 2.3 cm with attached submandibular. gland measuring 4.0 X 3.0 x 1.7 cm. The specimen is divided into levels 1A,. 1B, level 2, level 3 and level 4. Three possible lymph nodes are identified. ranging in greatest dimension from 0.8 to 1.3 cm in level 1A. One lymph node. is identified measuring in greatest dimension 1.6 cm in level 1B. Four. possible lymph nodes are identified ranging in greatest dimension from 0.2 to. 3.5 cm in level 2. The largest lymph node is serially cross sectioned. revealing a cystic and necrotic cut surfaces. Eight possible lymph nodes are. identified ranging in greatest dimension from 0.7 to 2.5 cm in level 3. Four. possible lymph nodes are identified ranging in greatest dimension from 0.4 to. 1.6 cm in level 4. The submandibular gland is serially cross sectioned revealing a lobular. tan-yellow unremarkable parenchyma. Cassette code: 7A one lymph node, bisected, level 1A. 7B two lymph nodes, level 1A. 7C one lymph node, level 1B. 7D representative of submandibular gland. 7E 7F representative of largest lymph node, level 2. 7G three possible lymph nodes, level 2. 7H two possible lymph nodes, level 3. 7I 7J three possible lymph nodes in each, level 3. 7K four possible lymph nodes, level 4. 7L three possible lymph nodes, level 4. 7M one possible lymph node (received as a separate fragment from the main. specimen). INTRAOPERATIVE CONSULTATION: PART 1AFS: ANTERIOR AND POSTERIOR MARGINS, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 1BFS: ANTERIOR TONGUE MARGIN, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 1CFS: POSTERIOR TONGUE MARGIN, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 1DFS: ANTERIOR FLOOR OF MOUTH MARGIN, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. MALIGNANT. C. MICROSCOPIC FOCUS OF INVASIVE CLEAR CELL CARCINOMA AND SKELETAL MUSCLE. PART 1EFS: POSTERIOR FLOOR OF MOUTH MARGIN, SHAVE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. MALIGNANT. C. MICROSCOPIC FOCUS OF INVASIVE SQUAMOUS CELL CARCINOMA. D. SUBMUCOSAL SOFT TISSUE. PART 2AFS: ANTERIOR FLOOR OF MOUTH MARGIN (frozen section) -. A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT, NO MUCOSA. PART 3AFS: POSTERIOR FLOOR OF MOUTH (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 4AFS: MEDIAL POSTRIOR FLOOR OF MOUTH/TONGUE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. MALIGNANT. C. INVASIVE SQUAMOUS CELL CARCINOMA. PART 5AFS: NEW POSTERIOR MARGIN (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. PART 6AFS: DEEP MUSCLE MARGIN (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR PRESENT. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. caa. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics determined by. the. Department of Pathology, as required by the CLIA. regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue fixation. ranges from a minimum of 2 to a maximum of 84 hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of. (""CLIA"") as qualified to perform high-complexity clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND SALIVARY GLAND. TUMORS. SPECIMEN TYPE: Resection: Right hemiglossectomy. TUMOR SITE: Oral Cavity. TUMOR SIZE: Greatest dimension: 4.2 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2. PRIMARY TUMOR (pT): pT3. REGIONAL LYMPH NODES (pN): pN2b. Number of regional lymph nodes examined: 24. Number of regional lymph nodes involved: 5. DISTANT METASTASIS (pM): pMX. MARGINS: Cannot be assessed. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Present. PERINEURAL INVASION: Present. PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: T3 M2 of right oral/tongue. PROCEDURE: Hemi-glossectomy and neck dissection. SPECIFIC CLINICAL QUESTION: Margins and nodes. OUTSIDE TISSUE DIAGNOSIS: Yes, squamous cell carcinoma. PRIOR MALIGNANCY: No.. CHEMORADIATION THERAPY: No. ORGAN TRANSPLANT: No. IMMUNOSUPPRESSION: No. OTHER DISEASES: No. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Right Hemi Glossectomy. Stain/cnt. Block. H&E x 1. F. H&E x 1. G. H&E X 1. H. H&E X 1. I. H&E X 1. AFS. H&E x 1. BFS. H&E X 1. CFS. H&E x 1. DFS. H&E x 1. EFS. Part 2: Anterior floor of mouth. Stain/cnt. Block. H&E x 1. AFS. Part 3: Posterior floor of mouth. Stain/cnt Block. H&E x 1. AFS. Part 4: Medial posterior floor of mouth. Stain/cnt. Block. H&E x 1. AFS. Part 5: New posterior margin. Stain/cnt. Block. H&E X 1. AFS. Part 6: Deep muscle margin. Stain/cnt. Block. H&E X 1. AFS. Part 7: Right Neck Dissection. Stain/cnt. Block. H&E x 1. A. H&E X 1. B. H&E x 1. C. H&E x 1. D. H&E x 1. E. H&E X 1. F. H&E x 1. G. H&E x 1. H. H&E x 1. I. H&E x 1. J. H&E x 1. K. H&E x 1. L. H&E X 1. M. TC1.","The patient underwent a right hemiglossectomy with neck dissection for a T3 squamous cell carcinoma of the oral cavity. The tumor was moderately differentiated, keratinizing, and involved the intrinsic tongue muscles. Vascular and perineural invasion was present. The anterior, posterior, and deep tongue margins were free of carcinoma, but the carcinoma extended to the anterior and posterior floor of the mouth margins. The pathologic stage was pT3 N2b. The re-resection of the anterior and posterior floor of the mouth margins showed no tumor. The biopsy of the medial posterior floor of the mouth/tongue showed invasive squamous cell carcinoma based on the original frozen section slides. The neck dissection, levels 1 through 4, showed metastatic squamous cell carcinoma in five of 24 lymph nodes, involving levels 1A and 2, with extranodal extension and vascular invasion present. Microscopic examination substantiated the diagnosis of invasive squamous cell carcinoma.","The patient underwent a right hemiglossectomy with neck dissection for a T3 squamous cell carcinoma of the oral cavity. The tumor was moderately differentiated, keratinizing, and involved the intrinsic tongue muscles. Vascular and perineural invasion was present. The anterior, posterior, and deep tongue margins were free of carcinoma, but the carcinoma extended to the anterior and posterior floor of the mouth margins. The pathologic stage was pT3 N2b. The re-resection of the anterior and posterior floor of the mouth margins showed no tumor. The biopsy of the medial posterior floor of the mouth/tongue showed invasive squamous cell carcinoma based on the original frozen section slides. The neck dissection, levels 1 through 4, showed metastatic squamous cell carcinoma in five of 24 lymph nodes, involving levels 1A and 2, with extranodal extension and vascular invasion present. Microscopic examination substantiated the diagnosis of invasive squamous cell carcinoma."
TCGA-HS-A5N8,TCGA-HS-A5N8.23C57E99-5BF2-4CD2-AC62-E58D3FBBF273,"Sample Type TUMOUR. Diagnosis. Leiomyosarcoma. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Uterus, Ovary. Tumour Size (cm). 10. Histology. Leiomyosarcoma. Grade/Differentiation. X. Pathological T. T2b. Pathological N. NX. Clinical M. M0. Histology Comments. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.","The pathology report indicates a diagnosis of Leiomyosarcoma, a type of cancer, with the sample collected from the uterus and ovary. The tumour size was 10cm. Microscopic examination revealed features consistent with Leiomyosarcoma, with a grade/differentiation of X. The tumour was classified as T2b, indicating a specific tumour size and extent, while lymph nodes were not assessed (NX). The cancer had not metastasized (M0).","The pathology report indicates a diagnosis of Leiomyosarcoma, a type of cancer, with the sample collected from the uterus and ovary. The tumour size was 10cm. Grade/differentiation could not be assessed. The tumour was classified as T2b, indicating a specific tumour size and extent, while lymph nodes were not assessed (NX). The cancer had not metastasized (M0)."
TCGA-E2-A14V,TCGA-E2-A14V.DC8FD7C7-A908-4B90-860F-04984244167C,"SPECIMENS: A. EXCISION LEFT BREAST. B. LEFT AXILLARY SKIN TAG. C. LEFT AXILLA S.L.N. #1. D. LEFT AXILLA S.L.N. #2. E. LEFT AXILLARY CONTENTS. SPECIMEN(S): A. EXCISION LEFT BREAST. B. LEFT AXILLARY SKIN TAG. C. LEFT AXILLA S.L. N. #1. D. LEFT AXILLA S.L.N. #2. E. LEFT AXILLARY CONTENTS. GROSS DESCRIPTION: A. EXCISION LEFT BREAST. Received fresh labeled with the patient's identification, ""Excision Left Breast"" is a 130g, 8 x 11 x 4cm oriented. (Single-Anterior, Double-Lateral, Triple-Superior) left lumpectomy with 5 x 2 cm tan pink unremarkable skin ellipse. Ink Code: Anterior-Yellow, Posterior-Black, Medial-Green, Lateral-Red, Superior-Blue, Inferior-Orange. The. specimen is serially sectioned from medial to lateral into 8 slices to reveal a 3 x 3 x 2.3cm gray white firm ill defined. mass, 0.5cm from the closest anterior-superior margins in slices 3-6. A portion of the specimen is submitted for. tissue procurement. Representative sections are submitted as follows: A1: medial margin slice 1. A2-A3: superior margin slice 2. A4: area next to mass slice 2. A5: skin slice 3. A6: mass with anterior margin slice. 3. A7: mass with deep margin slice 3. A8: mass with anterior margin slice 3. A9: mass with deep margin slice 3. A10: anterior/superior margin slice 4. A11: superior margin slice 4. A12: mass with anterior margin slice 4. A13: mass with deep margin slice 4. A14: mass with anterior margin slice 4. A15: mass with anterior/inferior margin slice 4. A16: mass slice 4. A17: deep margin slice 4. A18: deep/inferior margin slice 4. A19: mass with anterior margin slice 5. A20: superior margin slice 5. A21: mass slice 5. A22: mass with deep margin slice 5. A23-A24: anterior margin slice 5. A25: mass slice 5. A26-A27: mass with deep margin slice 5. A28-A29: mass with anterior margin slice 6. A30-A31: mass slice 6. A32: deep margin slice 6. A33: next to mass slice 7. A34-A35: deep margin slice 7. A36: lateral margin slice 8. B. LEFT AXILLARY SKIN TAGS. Received in formalin are two polypoid skin tags, 0.1 and 0.3 cm in diameter. Submitted entirely in cassette B1. C. LEFT AXILLARY SLN #1. Received fresh is a tan pink lymph node 1.0 x 0.6 x 0.3cm. The specimen is bisected and a touch prep is taken. Toto. C1. D. LEFT AXILLARY SLN #2. Received fresh is a tan pink lymph node 1.5 x 1.2 x 0.6cm. The specimen is bisected and a touch prep is taken. Toto. D1. E. LEFT AXILLARY CONTENTS. Received in formalin is a piece of yellow-tan adipose tissue, 9.5 x 0.5 x 2.7 cm. Multiple lymph nodes are identified. ranging in size from 0.1 to 2.7 cm. The larger lymph nodes are bisected and have variegated pink-tan coloration. There is a blood vessel, 0.9 cm and the length and 0.4 cm in diameter, which is clipped at both ends. It contains. blood clot. Specimen is submitted entirely: E1-E2: 6 lymph nodes each. E3-E5: 2 lymph nodes each. E6-E8: 1 lymph node each. E9-E10: 1 lymph node. E11-E25: remainder of soft tissue. DIAGNOSIS: A. BREAST, LEFT, WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (SBR GRADE 3). - INVASIVE CARCINOMA MEASURES 3 CM IN GREATEST DIMENSION. - MARGINS, FREE OF TUMOR. - LYMPHVASCULAR INVASION IS PRESENT. - DUCTAL CARCINOMA IN SITU (DCIS), SOLID AND MICROPAPILLARY. TYPES, NUCLEAR GRADE 3, WITH NECROSIS AND MICROCALCIFICATIONS. DCIS IS WITHIN 3 MM OF THE SUPERIOR MARGIN AND IS WITHIN. 4 MM OF THE POSTERIOR MARGIN. - SKIN, NO TUMOR SEEN. B. AXILLA, LEFT, SKIN TAG, EXCISION: - ACROCHORDONS. C. SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: - METASTATIC CARCINOMA (0.3 CM IN SIZE) TO ONE LYMPH NODE (1/1). D. SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: - METASTATIC CARCINOMA (1.5 CM IN SIZE) TO ONE LYMPH NODE WITH. FOCAL EXTRANODAL EXTENSION (1/1). E. AXILLARY CONTENTS, LEFT, DISSECTION: - METASTATIC CARCINOMA (0.8 CM IN SIZE) TO ONE OF 22 LYMPH NODES. (1/22). SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Tumor Site: Lower inner quadrant. Margins: Negative. Distance from closest margin: 0.5cm. anterior. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Present. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 3 /24 Extranodal extension. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 40%. DCIS Type: Solid. Micropapillary. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. Location of CA++: DCIS. Stroma. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Pending. Pathological staging (pTN): pT2N1. CLINICAL HISTORY: 5cm tumor-Invasive Cancer on Core Bx. Lower Inner Quadrant Left Breast. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. INTRAOPERATIVE CONSULTATION: A. GROSS INSPECTION: 3cm mass, 0.5cm from the closest Anterior margin. TPC-TPD: Positive for Adenocarcinoma. Diagnoses called to Dr. at. (A) and. (C-D) by Dr. ADDENDUM: SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: A16. Interpretation: POSITIVE. Intensity: % Tumor Staining: 100%. Fish Ordered: No. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and nn longer than 24 hours. Her2 analysis. was performed using the FDA approved Dako HercepTest (TM) test kit. using rabbit anti-. human HER2. This assay was not modified. External kit-slides provided by the manufacturer (cell lines with high,. low and negative HER2 protein expression) and in-house known HER2 amplified control tissue were evaluated along. with the test tissue. Adequate, well preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2 immunohistochemical stain is guided by published results in the medical literature,. information provided by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from ASCO. and. CAP. and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology Department takes full responsibility. for this test's performance. Microscopic/Diagnostic Dictation Pathologist,. Final Review: Pathologist,. Final Review: Pathologist. Final: Pathologist,. Addendum: Pathologist. Addendum Final: Pathoiogist, 1.","The patient underwent a wide local excision of the left breast, which revealed invasive ductal carcinoma, poorly differentiated (SBR grade 3), measuring 3 cm in greatest dimension. The margins were free of tumor. Lymphovascular invasion was present. Ductal carcinoma in situ (DCIS), solid and micropapillary types, nuclear grade 3, with necrosis and microcalcifications, was also identified, within 3 mm of the superior margin and within 4 mm of the posterior margin. The skin was uninvolved by tumor. The sentinel lymph node #1 showed metastatic carcinoma (0.3 cm in size) to one lymph node, and sentinel lymph node #2 showed metastatic carcinoma (1.5 cm in size) with focal extranodal extension. The axillary contents dissection revealed metastatic carcinoma (0.8 cm in size) to one of 22 lymph nodes. The patient's clinical history included a 5 cm tumor with invasive cancer on core biopsy in the lower inner quadrant of the left breast. The preoperative diagnosis was left breast cancer. The HER2 results were positive, with 100% tumor staining. The pathology report also noted the presence of acrochordons in the left axillary skin tag excision.","The patient underwent a wide local excision of the left breast, which revealed invasive ductal carcinoma, poorly differentiated (SBR grade 3), measuring 3 cm in greatest dimension. The margins were free of tumor. Lymphovascular invasion was present. Ductal carcinoma in situ (DCIS), solid and micropapillary types, nuclear grade 3, with necrosis and microcalcifications, was also identified, within 3 mm of the superior margin and within 4 mm of the posterior margin. The skin was uninvolved by tumor. The sentinel lymph node #1 showed metastatic carcinoma (0.3 cm in size) to one lymph node, and sentinel lymph node #2 showed metastatic carcinoma (1.5 cm in size) with focal extranodal extension. The axillary contents dissection revealed metastatic carcinoma (0.8 cm in size) to one of 22 lymph nodes. The patient's clinical history included a 5 cm tumor with invasive cancer on core biopsy in the lower inner quadrant of the left breast. The preoperative diagnosis was left breast cancer. The HER2 results were positive, with 100% tumor staining. The pathology report also noted the presence of acrochordons in the left axillary skin tag excision."
TCGA-FB-AAQ6,TCGA-FB-AAQ6.EF255DB8-CEE7-4882-B897-FA84696211D0,"Gross Description: Distal pancreas with spleen: Received is a 188 gram distal pancreatectomy and. spleen measuring 14.5 (ML) X 11.5 (SI) X 5.8 (AP) cm, the pancreas measures 12 (ML) x 3 (SI) x 2.5 (AP). cm, the spleen measures. 10.5 (SI) X 5.8 (AP) X 3.5 (ML) cm. There is an indurated white-yellow. lesion in the body of the pancreas [2 (ML) X 2 (AP) x 1.4 (SI) cm], and. pancreatic tissue distal to this looks atrophic. It is located. approximately 1 cm from the distal pancreatic margin. The tumor nodule is. greater than 5 cm from the spleen and does not grossly involve the splenic. artery or splenic vein. The spleen is serially sectioned and is grossly. normal. The splenic hilar fat and peripancreatic fat are searched for. lymph nodes. Microscopic Description: Diagnosis Details: Invasive ductal adenocarcinoma, moderately differentiated. - Tumor arising in the tail of the pancreas and superficially invading peripancreatic fat. - Tumor measures 2.0 cm in greatest dimension. Tumor approaches to less than 0.1 cm from peritonealized radial margin. - Pancreatic parenchymal and vascular margins free of tumor. - Extensive perineural invasion present. - No angiolymphatic invasion identified. - Six peripancreatic lymph nodes, negative for malignancy (0/6). - Three splenic hilar lymph nodes, negative for malignancy (0/3). - AJCC Pathologic Staging (7th edition): pT3 NO. - Moderate pancreatic intraepithelial neoplasia/PanIn 2. - Background chronic pancreatitis present. - Spleen and splenic vasculature, negative for malignancy. Comments: Formatted Path Reports: PANCREAS TISSUE CHECKLIST. Specimen type: Pancreatectomy and splenectomy. Tumor site: Tail. Tumor size: 2 cm. Histologic type: Adenocarcinoma, ductal type. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/9 positive for metastasis (Regional 0/9). Lymphatic invasion: Absent. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.","The microscopic description reveals invasive ductal adenocarcinoma, moderately differentiated, arising in the tail of the pancreas, superficially invading peripancreatic fat, measuring 2.0 cm in greatest dimension, approaching less than 0.1 cm from the peritonealized radial margin, with pancreatic parenchymal and vascular margins free of tumor. Extensive perineural invasion is present, but no angiolymphatic invasion is identified. Six peripancreatic lymph nodes and three splenic hilar lymph nodes are negative for malignancy. The AJCC Pathologic Staging is pT3 N0. Moderate pancreatic intraepithelial neoplasia/PanIn 2 and background chronic pancreatitis are also present.","The microscopic description reveals invasive ductal adenocarcinoma, moderately differentiated, arising in the tail of the pancreas, superficially invading peripancreatic fat, measuring 2.0 cm in greatest dimension, approaching less than 0.1 cm from the peritonealized radial margin, with pancreatic parenchymal and vascular margins free of tumor. Extensive perineural invasion is present, but no angiolymphatic invasion is identified. Six peripancreatic lymph nodes and three splenic hilar lymph nodes are negative for malignancy. The AJCC Pathologic Staging is pT3 N0. Moderate pancreatic intraepithelial neoplasia/PanIn 2 and background chronic pancreatitis are also present."
TCGA-BJ-A0ZA,TCGA-BJ-A0ZA.01ABC869-F3BE-4420-AB0D-D766DBE5CE71,"PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Multinodular goiter. PROCEDURE: Total thyroidectomy. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not apswered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. FINAL DIAGNOSIS: PART 1: THYROID, TOTAL THYROIDECTOMY (11.3 GRAMS) -. A. PAPILLARY.THYROID CARCINOMAS, TWO FOCI: a. LEFT LOBE-ENCAPSULATED FOLLICULAR VARIANT (3.0 CM), CONFINED TO THYROID, NO. CAPSULAR OR ANGIOLYMPHATIC INVASION. b. RIGHT LOBE-MICROCARCINOMA, (LESS THAN 0.1 CM), CONFINED TO THYROID, NO. ANGIOLYMPHATIC INVASION. B. PATHOLOGIC STAGE: pT2 NO. C. MULTINODULAR HYPERPLASIA. D. CHRONIC LYMPHOCYTIC THYROIDITIS. PART 2: LYMPH NODE, CENTRAL COMPARTMENT, BIOPSY -. TWO LYMPH NODES, NO TUMOR PRESENT (0/2). CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe, Left Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 3 cm. HISTOLOGIC TYPE: Papillary carcinoma, follicular variant. PATHOLOGIC STAGING (PTNM): pT2. pNO. Number of regional lymph nodes examined: 2. Number of regional lymph nodes involved: 0. pMX. MARGINS: Margins uninvolved by carcinoma. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Absent. ADDITIONAL PATHOLOGIC FINDINGS: Thyroiditis.","The patient underwent a total thyroidectomy for a multinodular goiter. The final diagnosis is as follows: two foci of papillary thyroid carcinoma, one in the left lobe (3.0 cm, encapsulated follicular variant, confined to the thyroid with no capsular or angiolymphatic invasion) and one in the right lobe (less than 0.1 cm, confined to the thyroid with no angiolymphatic invasion). The pathologic stage is pT2 N0. Additional findings include multinodular hyperplasia and chronic lymphocytic thyroiditis. Two lymph nodes examined from the central compartment were negative for tumor. The margins are uninvolved by carcinoma, and there is no venous or lymphatic invasion.","The patient underwent a total thyroidectomy for a multinodular goiter. The final diagnosis is as follows: two foci of papillary thyroid carcinoma, one in the left lobe (3.0 cm, encapsulated follicular variant, confined to the thyroid with no capsular or angiolymphatic invasion) and one in the right lobe (less than 0.1 cm, confined to the thyroid with no angiolymphatic invasion). The pathologic stage is pT2 N0. Additional findings include multinodular hyperplasia and chronic lymphocytic thyroiditis. Two lymph nodes examined from the central compartment were negative for tumor. The margins are uninvolved by carcinoma, and there is no venous or lymphatic invasion."
TCGA-AA-A01C,TCGA-AA-A01C.DDD08E2A-031B-4488-B96B-74697603B470,"Cample ID #. Diagnosis: Right hemicolectomy preparation tumor-free resection margins, several tubular colon. adenomas of the mucous membrane with up to moderate dysplasia (synonymous: mild. intraepithelial neoplasia), with several more recent mucosal ulcerations and displaying. status post excision of further adenomas of the colon mucosa (compare previous findings. XXXXXXXXXXX and xxxxxxxxxxxxx) and with inclusion of a colorectal double carcinoma. characterized as an ulcerated, moderately differentiated type of adenocarcinoma in the. ascending colon and in the transverse colon (8 cm and 29 cm aborally of the ileocecal. valve), both with invasion of the lamina muscularis propria, and with invasion of the. lymphatic vessels and with a total of three local lymph node metastases (G2, pT2 L1, V0. R0, pN1 3/21).","The pathology report reveals several tubular adenomas of the colon mucosa with up to moderate dysplasia, recent mucosal ulcerations, and a history of excised adenomas. A colorectal carcinoma was identified, characterized as an ulcerated, moderately differentiated adenocarcinoma in the ascending and transverse colon, measuring 8 cm and 29 cm from the ileocecal valve, respectively. The cancer invaded the lamina muscularis propria and lymphatic vessels, with three local lymph node metastases (G2, pT2 L1, V0, R0, pN1 3/21).","The pathology report reveals several tubular adenomas of the colon mucosa with up to moderate dysplasia, recent mucosal ulcerations, and a history of excised adenomas. A colorectal carcinoma was identified, characterized as an ulcerated, moderately differentiated adenocarcinoma in the ascending and transverse colon, measuring 8 cm and 29 cm from the ileocecal valve, respectively. The cancer invaded the lamina muscularis propria and lymphatic vessels, with three local lymph node metastases (G2, pT2 L1, V0, R0, pN1 3/21)."
TCGA-BQ-7044,TCGA-BQ-7044.df325d36-7617-4333-b4e4-3d18f5f651dc,"Biiling Type: Clinical Diagnosis & History: Left renal mass,. Specimens Submitted: 1: SP: Left kidney and adrenal. DIAGNOSIS: 1). KIDNEY AND ADRENAL GLAND, LEFT NEPURECTOMY AND. ADREMALECTOMY. - RENAL CELL CARCINOMA, PAPILLARY TYPE, WITH FOCAL SPINDLE. CELL (SARCOMATOID) GROWTIT AND EXTENSIVE NECROSIS. THE TUMOR. GREATEST DIAMETER IS 10.0 CM. THE TUMOR EXTENDS THROUGH THE. RENAL CAPSULE BUT is CONFINED WITHIN GEROTA'S FASCIA. NO. INVASION OF THE RENAL VEIN IS IDENTIFIED. ALL SURGICAL. MARGINS ARE FREE OF TUMOR. THE NON-NEOPLASTIC KIONEY IS. UNREMARKABLE. THE ADRENAL GLAND IS UNREMARKABLE. JATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh labelled ""Jeft kidney and. adrenal"". It consists of a kidney with attached adrenal gland,. almost entirely covered by adipose tissue, which totally weighs. 720 grams. The kidney measures 14 em in superior-inferior, 10 em. anterior - posterior, and 9.5 cm medial to lateral. The adrenal. gland measures 4.5 X 2 x 0.7 CB, and on cut. section is. unremarkable. The surgical margins of the vein and of the ureter. are shaved off. The kidney is bisected to reveal an almost. entirely necrotic mass, which is located in the cortical portion. of the specimen. The mass measures 10 x 6 x 5 cm, and is. centrally, diffusely occupied by brown necrotic tissue. In the. perionetal portion, Line consists of soft, yellow to dark end. lissue. The mass appears encapsulated and well demarested. in the most auporior portion wheee it appoars to infiltrate the. adipose Lissue. The external surtace consista is!. fibregs issne anso it is unelear if residual kiriney. the tumor. The pelvio tat appears not involved by the. The noinvolved kidney appears unremarkable. Representativo sections are subnitted. Nommary of. AG adtenal ;land. IVM - creters: :- veita. OK - in kidney. Histo. Procadure Mame. Resoat. RAE. ,: Sead -. 2011. 1. M.","The microscopic description of the left kidney and adrenal gland specimen reveals a renal cell carcinoma, papillary type, with focal spindle cell (sarcomatoid) growth and extensive necrosis. The tumor measures 10.0 cm in greatest diameter and extends through the renal capsule but is confined within Gerota's fascia without invasion of the renal vein. The surgical margins are free of tumor. The non-neoplastic kidney is unremarkable, and the adrenal gland is also unremarkable.","The microscopic description of the left kidney and adrenal gland specimen reveals a renal cell carcinoma, papillary type, with focal spindle cell (sarcomatoid) growth and extensive necrosis. The tumor measures 10.0 cm in greatest diameter and extends through the renal capsule but is confined within Gerota's fascia without invasion of the renal vein. The surgical margins are free of tumor. The non-neoplastic kidney is unremarkable, and the adrenal gland is also unremarkable."
TCGA-V5-AASX,TCGA-V5-AASX.0C4B06F7-3B4E-422B-A73D-9393CC4E56FF,"Medical Record #: Patient ID: Clinician: Date Obtained: Clinician Phone: Date Received: Specimen: Esophagus Blopsy. Pertinent History: Dysphagia, weight loss. ICD-9 Codes: Einal Pathologic Diagnosis. DISTAL ESOPHAGUS, BIOPSY: MODERATELY DIFFERENTIATED ADENOCARCINOMA, SEE COMMENT. COMMENT: THE BIOPSIES ARE DIAGNOSTIC OF ADENOCARCINOMA AND WITH THE PRESENCE OF INTESTINALMETAPLASIA, ORIGIN IN PREEXISTING. BARRETT'S ESOPHAGUS is FAVORED. THE SUDES ARE REVIEWED BY. AND WE CONCUR WITH THIS INTERPRETATION. THE RESULTS ARE CALLED TO. ON. AT APPROXIMATELY. . Department of Pathology. Grass Examination. Received are multiple fragments of tan, grey tissue measuring up to 0.1 cm which are submitted in cassette 1A. Microscopic Description. Sections show fragments of esophageal mucosa which contains a malignant epithellal neoplasm. The neoplasm Is composed of malignant. epithellal cells which form poorly formed glandular structures and Inflitrate within Inflamed fibromuscular stroma. There are fragments. within the blopsles of benign squarnous epitheilum and glandular epithellum with intestinal metaplasia.","The patient's esophagus biopsy revealed moderately differentiated adenocarcinoma, with a favored origin in pre-existing Barrett's esophagus. Microscopic examination showed fragments of esophageal mucosa containing a malignant epithelial neoplasm composed of poorly formed glandular structures infiltrating within inflamed fibromuscular stroma. Additionally, fragments of benign squamous epithelium and glandular epithelium with intestinal metaplasia were present within the biopsy samples.","The patient's esophagus biopsy revealed moderately differentiated adenocarcinoma, with a favored origin in pre-existing Barrett's esophagus. Microscopic examination showed fragments of esophageal mucosa containing a malignant epithelial neoplasm composed of poorly formed glandular structures infiltrating within inflamed fibromuscular stroma. Additionally, fragments of benign squamous epithelium and glandular epithelium with intestinal metaplasia were present within the biopsy samples."
TCGA-OR-A5K1,TCGA-OR-A5K1.54EFE89F-32E0-4E95-A841-728648D9D11E,"PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 2. SEX: M. BIRTHDATE: ADM DATE: OPER DATE: PROCEDURE: APMI. ADDITIONAL REPORT FOLLOWING ADDITIONAL SECTIONS AND IMMUNOHISTOCHEMISTRY: Please see diagnosis below. PROCEDURE: APDX. 1. Adrenal gland, left, resection: Adenocortical carcinoma, low-grade by. mitotic activity, with capsular and vascular invasion. Ki-67 proliferation. marker shows a proliferation rate above that typically found in benign tumors. See COMMENT. COMMENT: This adrenocortical neoplasm has a very low mitotic activity as assessed by. counting of mitotic figures. The Ki-67 proliferation marker shows a. proliferation rate that is consistent with the diagnosis of low grade. adrenocortical carcinoma. In addition, research immunostains show a similar. proliferation rate using topoisomerase 2-alpha. Furthermore, the tumor shows. diffuse nuclear immunoreactivity for cyclin E which is also consistent with a. diagnosis of carcinoma. (These research stains are not performed by a. certified Tab and therefore are not billed to the patient. signing staff pathologist, have personally. examined and interpreted the stroes from this case. ""This test was developed and its performance characteristics determined by the. linical Immunoperoxidase Laboratory. It has not been. cleared or approved by the U.S. Food and Drug Administration. (The FDA has. determined that such clearance is not necessary. This test is used for. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 3. SEX: M. BIRTHDATE: PAT TYP_. ADM DATE: OPER DATE: clinical purposes. It should not be regarded as investigational or for. research. This laboratory is certified under the Clinical Laboratory. Improvement Amendments of 1988 [""CLIA""] as qualified to perform high. complexity testing)."". OPER DATE: PROCEDURE: SPHS. year-old male with left adrenal mas. PROCEDURE: SPGD. 1. ""Left adrenal"" Received fresh in a medium container is a 110 gram adrenal. with a scant amount of attached yellow adipose, 7.9 x 6.2 x 5.7 cm. The cut. surface is remarkable for a 6.2 x 5.3 x 6.0 cm, tan-brown, faintly-nodular,. soft, well-circumscribed tumor. The tumor has focal areas of bright-yellow. necrosis occupying approximately 15% of the cut surface. Tumor abuts the. margin. A 1.1 x 2.3 x 0.5 cm segments of normal adrenal gland is present. NO. other abnormalities are noted. Photographs have been taken. 1A&B. Tumor to normal. 1C-G. Tumor to capsule. 1H. Normal adrenal. PROCEDURE: SPDX. 1. Adrenal gland, left, resection: Adrenocortical carcinoma, low-grade by. mitotic activity, with capsular invasion. Additional report pending additional. sections and immunohistochemistry. , the signing staff pathologist, have personally. examined and interpreted the slides from this case. Criteria In 12/22/12.","A 1-year-old male underwent a left adrenal gland resection due to a left adrenal mass. The microscopic description of the tumor shows a 6.2 x 5.3 x 6.0 cm, tan-brown, faintly-nodular, soft, well-circumscribed tumor with focal areas of bright-yellow necrosis occupying approximately 15% of the cut surface. The tumor abuts the margin and has a 1.1 x 2.3 x 0.5 cm segment of normal adrenal gland present. The tumor is diagnosed as an adenocortical carcinoma, low-grade by mitotic activity, with capsular and vascular invasion. The Ki-67 proliferation marker shows a proliferation rate above that typically found in benign tumors, and research immunostains show a similar proliferation rate using topoisomerase 2-alpha and diffuse nuclear immunoreactivity for cyclin E, which is consistent with a diagnosis of carcinoma.","A male patient underwent a left adrenal gland resection due to a left adrenal mass. The microscopic description of the tumor shows a 6.2 x 5.3 x 6.0 cm, tan-brown, faintly-nodular, soft, well-circumscribed tumor with focal areas of bright-yellow necrosis occupying approximately 15% of the cut surface. The tumor abuts the margin and has a 1.1 x 2.3 x 0.5 cm segment of normal adrenal gland present. The tumor is diagnosed as an adenocortical carcinoma, low-grade by mitotic activity, with capsular and vascular invasion. The Ki-67 proliferation marker shows a proliferation rate above that typically found in benign tumors, and research immunostains show a similar proliferation rate using topoisomerase 2-alpha and diffuse nuclear immunoreactivity for cyclin E, which is consistent with a diagnosis of carcinoma."
TCGA-AC-A23C,TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938,"Hospital of Origir. QC Pathologist: FINAL PATHOLOGIC DIAGNOSIS: A. Left axillary sentinel lymph node: One lymph node containing metastatic carcinoma. Confirms frozen section diagnosis. Size of involvement within the node: 0.3 cm. B. Left breast mastectomy: Residual invasive ductal carcinoma. Size: 2.5 cm. Architectural score: 2/3. Nuclear score: 2/3. Mitotic score: 1/3. Total score: 5/9, Grade I. Carcinoma is adjacent to previous biopsy cavity. No evidence of skin or nipple involvement. Deep margin of excision is free of carcinoma. Prognostic panel was performed on the original biopsy and. will not be repeated unless requested. Multifocal areas of ductal carcinoma in situ present in. uninvolved quadrants of breast. DCIS is high grade comedo carcinoma type. Largest area of confluent DCIS is approximately 1.0 cm. TNM Classification: T2 pN1 MX. COMMENTS: CLINICAL HISTORY: Preoperative Diagnosis: Left modified radical mastectomy. with sentinel node mapping with frozen section. Invasive. ductal carcinoma, ER positive, PR positive, Ki-67 (MIB1). 33%. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Left axilla sentinel node with frozen section. B. Left breast. CODES: PROCEDURAL DEMOGRAPHICS: Accession Date/Time: GROSS DESCRIPTION: The snecimen is received in two containers labeled =. A. Auanionally labeled right sentinel node and contains a. 1.7 cm yellow tan fibrofatty soft tissue. The specimen is. bisected and entirely submitted for frozen section with the. residual entirely resubmitted for permanent section in. cassette A labeled. B. Additionally labeled left breast and contains a 641. gram, 20.0 x 13.5 x 7.0 cm simple mastectomy specimen. partially surfaced by a 17.5 x 9.3 cm ellips: of pink tan. wrinkled skin bearing a central 1.4 x 1.2 x 0.5 cm everted. nipple. No orientation is offered or possible. The deep. margin is inked and the specimen is serially sectioned to. reveal a 2.5 x 1.5 x 1.5 cm ill defined gray white gritty. mass that resides 3.5 cm from the skin surface and. approaches to within 3.5 cm of the inked deep margin. Located immediately adjacent to this mass is a 3.5 x 2.8 x. 2.3 cm shaggy, necrotic cavity consistent with previous. biopsy site. This cavity resides 1.5 cm below the skin. surface and approaches to within 3.5 cm of the inked deep. margin. The remainder of the cut surface is comprised of. predominantly yellow tan adipose tissue admixed with. moderate amounts of interspersed gray white fibrous tissue. No additional masses are identified. Also received in the same container is an 11.5 x 2.0 x 1.5. cm strip of pink tan wrinkled skin with adherent yellow tan. fibrofatty soft tissue. Sectioning reveals a yellow tan. fibrofatty cut surface with no discrete lesions. Representative sections are submitted in cassettes B1-B13. labeled. designated as follows: B1- nipple;. B2- inked deep margin, perpendicular; B3-B5-- mass; B6-B9--. previous biopsy cavity; B10-B12-- representative sections. from the three uninvolved quadrants; B13-- sections from. separately submitted skin and fibroadipose tissue. Additionally, a yellow and green cassette are submitted for. genomic research each labeled. INTRA-PROCEDURE CONSULTATION: A. Frozen section diagnosis: Metastatic neoplasm. approximately 0.3 mm on frozen section per Dr. margin. The specimen is inkt. is follows: Superficial -. blue, deep - black, superior - green, and inferior - orange. The specimen is serially sectioned in a medial to lateral. fashion to reveal a 0.9 x 0.8 x 0.6 cm white-tan, firm. well-defined mass/possible lymph node which extends to the. medial, superior, inferior, superficial margins, is within. 0.7 cm of the deep margin and greater then 1 cm from the. lateral margin. The mass is covered in a moderate amount of. overlying blue surgical dye. Remaining breast parenchyma is. approximately 10% tan, somewhat dense fibrous tissue. Cut. surfaces are also remarkable for a few foci of hemorrhage up. to 0.8 cm in greatest dimension The entire enecimen is. submitted in cassettes labeled. as follows: A1-A7 are in a medial to lateral fashion. A1 is a full. cross section of the mass to show the nearest superficial,. deep, superior, inferior margins; A2. Additional section of. the mass; A3-A7. Remaining full cross sections of the. specimen; A8. Medial margin and transverse sections; A9. Lateral margin and transverse sections. B. Additionally labeled ""2 - Left medial margin, old. 0.8 margin cm portion up, new of margin yellow-tan, down"" lobulated, and consists fibrofatty of a 1.9 breast x. 1.4 x. tissue, stitched to a Telfa pad to indicate that the new. margin tan-yellow, down; lobulated, fibrofatty inked and blue. friable cut. is face new margin is Sectioning. reveals. surfaces. No significant fibrous tissue or distinct nodular. lesions are identified. The entire specimen is submilted. sequentially in cassettes B1 and B2 labeled. INTRA-PROCEDURE CONSULTATION: MICROSCOPIC DESCRIPTION: THERAPEUTIC MARKERS. Test. Description. Breast Cancer Analvsis using Immuno-histochemistry,. 1. and Pathologist review. is a FDA approved adjunctive, computer-assisted and. interactive microscopy system which aids the pathologist in. the detection, classification, and counting of cells of. interest thereby standardizing slide scoring through. quantitative assessment of marker intensity, size and shape. Estrogen / Progesterone. Receptors ER/PR. ER = Rabbit Monocional Antibody (clone SP1). PR = Rabbit Monoclonal Antibody (Clone 1E2). Anti-Estrogen receptor (ER) primary antibody is a rabbit. monoclonal antibody (IgG) that is used for the qualitative. detection of estrogen receptor antigens in sections of. formalin-fixed, paraffin-embedded tissue on an automated. slide stainer platform used in conjunction with an indirect. biotin streptavidin detection system. The ER antibody is. directed against the epitrope present on human ER protein. located in the nucleus of norr. ind neoplastic cells. This. test is indicated as and aid in the management, prognosis,. and prediction of therapy outcome of breast cancer. Anti-Progesterone Receptor (PR) primary antibody is a rabbit. monocional antibody (IgG) that is used for the quantitative. detection of the A, B and C isoforms of human progesterone. receptor antigens in sections of formalin-fixed,. paraffin-embedded tissue on an automated slide stainer. platform used in conjunction with an indirect biotin. streptavidin detection system. This test is indicated as. and aid in the management, prognosis, and prediction of. therapy outcome of breast cancer. The significance of PR is. its role in determining the functionality of estrogen. receptors in breast cancer cells. The presence of estrogen. does not guarantee a response to endocrine therapy. One way. to evaluate the functionality of the ER present in breast. carcinoma is to determine if the proteins regulated by ER. are expressed. PR receptor is such a protein, and has. historically been-used to monitor the functionality of ER. The. measures the percentage of positively stained. nuclei of the tumor cells. Note: False negatives are possible. Positive staining for. receptor in the normal glands if present is a good internal. control, and increases the likelihood that a negative result. is a true negative. Ki-67 = Rabbit Monoclonal (clone 30-9). Anti-Ki-67 primary antibody is directed against the. C-terminal portion of the Ki-67 antigen, which is expressed. in the nuclei of proliferating cells (normal and. neoplastic). The antibody identifies proliferating activity. in sections of formalin-fixed, paraffin-embedded tissue on. an automated slide stainer platform used in conjunction with. an indirect biotin streptavidin detection system. Assessment of tumor proliferative activity, IHC staining of. tumor cell nuclei, can be used for prognosis and therapy. planning. Ideal for use with small breast cancer specimens. The percentage of positively stained tumor nuclei is. reported. The. is an indirect biotin melhod. Interpretation utilizes the. instrument. The. is a. Tissue Fixation. ER/PR testing guidelines were released which include. fixation recommendations. All tissue should be fixed in. neutral buffered formalin as soon as possible. Excisional. and mastectomy specimen tissue should be fixed for a minimum. of 6 and maximum of 72 hours. For tissue not fixed within. the optimal time period or if fixation time is unknown it. should be noted on report. Any negative Her2 IHC result. without optimal fixation time should have Her2 FISH testing. performed. FISH, HER2/neu refl to IHC: CYTOGENETIC RESULTSCylogenetic. Reference #: Test Setup Date: est. Completion Date: Specimen Source: Left breast. Clinical History: Invasive ductal carcinoma;. HER2 IHC: Not AvailableInterphase Cells: 30 Metaphase Cells: OFISH RESULTS:POSITIVE HER2 oncogene amplification detected. by FISH analysisRatio of HER2 to D17Z1 is 8.0 (average. count: HER2: 14.9, D17Z1: 1.9)nuc. sh(D17Z1x1. 3,HER2x5. 25)(3OJINTERPRETATION and COMMENTS; The. HER2 FISH assay (Abbott Molecular) revealed amplification of. the HER2 oncogene.A ratio of >2.2 is considered to indicate. amplification. Slides from this sample were evaluated by an in-house. pathologist and deemed adequate for HER2 FISH analysis. The. formalin fixation time was between 6 hours and 48 hours per. the submitting facility. Controls were performed and. provided the anticipated results. The imaging method was. manual. This case has been reviewed by at least 2 observers. Results from this test are intended for use as an adjunct to. prognosis in stage II, node positive breast cancer patients. Clinically relevant amplification has been documented only. when an invasive component is involved. Clinical correlation. is recommended. This test is also indicated as an aid in the. assessment of patients for whom Herceptin. treatment is being considered. The performance characteristics of this assay have been. determined by. Performance characteristics. refer to the analytical performance of the. test.Reference:\ Wolff et al. Arch Pathol Lab Med. Hospital of Origin: QC Pathologist: ADDENDUM REPORT. ADDENDUM REPORT NUMBER TWO. FISH RESULTS: Specimen Source: Left breast (. A1)POSITIVE HER2 oncogene amplification detected by FISH. analysisRatio of HER2 to D17Z1 is 8.0 (average count: HER2: 14.9, D17Z1: 1.9)nuc sh(D17Z1x1. 3,HER2x5. 25)(30][Specific. testing information from this report has been added to the. microscopic description). ADDENDUM REPORT NUMBER ONE. BREAST PROGNOSTIC PANEL: (test results on block A1). TEST RESULT REFERENCE RANGES. Estrogen Receptor: POSITIVE (91%) = 1% is Positive. < 1% is Negative. Staining Intensity: Strong. Progesterone Receptor: POSITIVE (53%) = 1% is Positive. < 1% is Negative. Staining Intensity: Strong. Ki-67 (MIB1) Proliferation Marker: HIGH (33%) > 20% is High. 10-20% is Borderline. < 10% is Low. These results were interpreted by I. Indiana. An additional addendum report will tollow when. Her-2-neu tests are completed. [Specific testing information and references have been added. to the microscopic description). The original diagnosis remains unchanged. EXAMINATION: MRI BRFAST. .ATERAL \. Completed: FULL RESULT: Indication: Newly diagnosed left breast cancer. Comparison: Multiple mammograms dating back to. FINDINGS: Bilateral breast MRI was performed with and without contrast. CAD-stream. computer-aided detection system was utilized. to obtain multiplanar and 3-D reconstruction images. Subtraction images. were created from dynamic contrast data. All. images were evaluated at a work station. The right breast demonstrates no abnormal areas of enhancement or. adenopathy. On the left, axillary lymph nodes are more hypervascular than on the. right but morphologically they are similar and. symmetric. In the anterior upper-outer quadrant of the left breast, there is a. 1.5 x 1.1 x 1.3 cm irregular enhancing mass. consistent with the patient's known malignancy. Multiple scattered nodules are identified throughout the left breast. #1-3 cm superior, posterior and medial to the known malignancy is a. 6 x 5 x 7 mm enhancing nodule. Review of the. prior mammograms demonstrates that this was not present prior to this. year's mammogram and therefore is highly. suspicious for a satellite lesion. #2--Approximately 1 cm posterior to the known malignancy is a 3 mm. nodular area of enhancement. #3--2.3 cm inferior and lateral to the known malignancy is a 5 mm. nodule These are all suspicious for satellite. lesions. #4--In the far lateral aspect of the breast, there is a 1-2 mm. enhancing nodule. #5--Even more laterally, is a 3-4 mm enhancing nodule. This contains a. fatty hilum and these latter two nodules are. likely lymph nodes given their far lateral location and appearance. #6--In the posterior medial left breast a 3 mm enhancing nodule is seen. #7- in the far medial skin of the left breast there is a 4 x 2 x 4 mm. enhancing nodule. This could represent either a. benign or malignant skin tesion and therefore clinical correlation is. recommended. Interspersed between the known malignancy and the suspected satellite. lesions, are vague areas of subthreshold nodular. enhancement. A 1.6 and 1.4 cm area of this type of enhancement is seen in. the medial breast. Comparison of the MIP. projections show that these of. .Il areas of scattered enhancement and. nodularity are very asymmetric to the right and. therefore may relate to additional disease Inclusion of all of the. areas of enhancement shows that a large percentage. of the breasts may be involved with disease measuring up to 8.0 x 6.8 cm. Multicentric disease should be excluded. If breast conservation therapy. is considered, then biopsy of one or more of the. nodules will be needed. The 7 mm lesion, 3 cm from the known malignancies. (#1) would likely be visible by ultrasound and. amenable to biopsy. Some of the smaller more posterior nodules in the. medial breast may not be visible by ultrasound. IMPRESSION: 1. The patient's known malignancy is identified in the anterior. upper-outer quadrant and measures 1.5 cm. There are. multiple scattered renhancing nodules seen within the breast that are. suspicious for satellite lesions. Biopsies as. clinically indicated should be performed. HISTORY. Allergies: NKDA. Current Meds: see attached list please. BP-. VITAL SIGNS: P. PHYSICAL. See proprocedure record. WNL. Abnormal. N/A. Mental Status. HEENT. Heart. Lunga. Abdomen. Pelvic Extremities Syndrome ear thritis, ostro arthritis. PMH: Surgical Hx: left brease biopsy. Family. Hx: - breast caneer. Abnormal (explain) Pathology Invasive dectal carcinonia. Lab/X-Ray: CC/Present Illness Normal left breastcancer, Sibronualgia, Signeris syndrome, rheumatoid. Admit / Pre-Op Diagnosia: Treatment. Plan: with central hode mapping. M.D. Time -. H&P Date. lignature. Surgery Date.","The patient has invasive ductal carcinoma in the left breast, with a size of 2.5 cm. The carcinoma is adjacent to the previous biopsy cavity and does not involve the skin or nipple. The deep margin of excision is free of carcinoma. The tumor is of grade I, with a total score of 5/9. Multifocal areas of ductal carcinoma in situ (DCIS) are present in the uninvolved quadrants of the breast, with the largest area of confluent DCIS measuring approximately 1.0 cm. The DCIS is of high-grade comedo carcinoma type. The sentinel lymph node contains metastatic carcinoma, with a size of involvement of 0.3 cm. The patient's breast cancer is ER positive, PR positive, and Ki-67 (MIB1) is 33%. The HER2/neu test is positive, with a ratio of HER2 to D17Z1 of 8.0. The microscopic description reveals a 0.9 x 0.8 x 0.6 cm white-tan, firm, well-defined mass/possible lymph node in the sentinel lymph node, with a moderate amount of overlying blue surgical dye. The breast parenchyma is approximately 10% tan, somewhat dense fibrous tissue, with a few foci of hemorrhage up to 0.8 cm in greatest dimension. The patient's MRI shows multiple scattered nodules in the left breast, suspicious for satellite lesions, with a large percentage of the breast involved with disease measuring up to 8.0 x 6.8 cm.","The patient has invasive ductal carcinoma in the left breast, with a size of 2.5 cm. The carcinoma is adjacent to the previous biopsy cavity and does not involve the skin or nipple. The deep margin of excision is free of carcinoma. The tumor is of grade I, with a total score of 5/9. Multifocal areas of ductal carcinoma in situ (DCIS) are present in the uninvolved quadrants of the breast, with the largest area of confluent DCIS measuring approximately 1.0 cm. The DCIS is of high-grade comedo carcinoma type. The sentinel lymph node contains metastatic carcinoma, with a size of involvement of 0.3 cm. The patient's breast cancer is ER positive, PR positive, and Ki-67 (MIB1) is 33%. The HER2/neu test is positive, with a ratio of HER2 to D17Z1 of 8.0. The microscopic description of the lymph node reveals a 0.9 x 0.8 x 0.6 cm white-tan, firm, well-defined mass, with a moderate amount of overlying blue surgical dye. The breast parenchyma is approximately 10% tan, somewhat dense fibrous tissue, with a few foci of hemorrhage up to 0.8 cm in greatest dimension. The patient's MRI shows multiple scattered nodules in the left breast, suspicious for satellite lesions, with a large percentage of the breast involved with disease measuring up to 8.0 x 6.8 cm."
TCGA-HC-A6AQ,TCGA-HC-A6AQ.1B1D93C4-54AB-43CA-B800-6807A81AA89A,"PROCEDURE DATE : REPORT DATE: Pre-Op Diagnosis. Prostate cancer. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Received in a single container labeled. - prostate"". is a previously inked, previously sectioned moderately distorted. prostate gland with attached bilateral seminal vosicles. The. specimen is received after tissue harvest for genomic study. Within. the specimen container are three tissue cassettes labeled. The specimen in the intact state weighs 67 grams. with the prostate gland measuring 5.5 x 5.0 x 5.0 cm. This has a. lobulated focally shaggy outer surface with prominent verumontanum. at the base. The urethra is 3.2 x 0.5 x 0.2 cm and patent with. evidence of compression by the lateral lobes. The cut surface. reveals multinodular gray tan to pink fibrotic cut surface with. focal nodular areas having a slight yellow discoloration. These are. scattered through both lateral lobes in the mid to proximal (basal). regions as well as focally extending to the posterior lobes on both. sides. A single discrete gross lesion is not identified. A few of. the chalky yellow appearing regions extend focally to within 0.1 cm. of the nearest inked surfaces. The seminal vesicles together are. 5.6 x 3.2 x 1.2 cm. These have lobulated tan pink outer surfaces. with areas of fragmentation. On sectioning there is a multicystic. gray tan fibrotic cut surface. No gross lesions are identified. Representative sections are submitted as labeled as follows: A -. radial apical (distal) margin, left; B - radial apical (distal). margin, right; C - shave vesical (proximal) margin; D - left lateral. lobe distal; E - right lateral lobe distal; F - left posterior lobe. distal; G - right posterior lobe distal; H - left lateral lobe mid. region; I - right lateral lobe mid region; J - left posterior lobe. mid region; K - right posterior lobe mid region; L - left lateral. lobe proximal region; M - right lateral lobe proximal region; N -. left posterior lobe proximal region; o - right posterior lobe. proximal region; P - origin of the seminal vesicles; Q -. representative left seminal vesicle; R - representative right. seminal vesicle. Microscopic Description: Reviewed are slides labeled. Final Diagnosis. Prostate, prostatectomy: Tumor characteristics: Histologic type: Adenocarcinoma. Prostate size: 76 grams, 5.5 x 5.0 x 5.0 cm. Tumor quantitation: Tumor involves approximately 5% of total. tissue volume. Gleason grade: Primary pattern: 3/5. Secondary pattern: 4/5. Total Gleason score: 7/10. Extraprostatic extension: Not identified (see comment) . Lymphovascular Seminal space invasion: Not identified. identified. vesicle involvement Not. High grade PIN: Present. Treatment effect: Not applicable. Surgical margin status: See comment. Lymph node status: Not applicable. Other: pTN stage: pT2c Nx PAS 9 SPC-A. Comments. Histologic sections demonstrate adenocarcinoma extending up to the. surface of the specimen along the left posterior lobe mid region. While definitive evidence of tumor transection is not identified,. this area is highly suspicious for extension of the neoplasm beyond. the plane of surgical resection. Further, while no extraprostatic. extension is identified in the sections examined, clinical. correlation and correlation with intraoperative findings is. recommended. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis.","The clinical history is not indicated. The prostate gland weighed 67 grams and measured 5.5 x 5.0 x 5.0 cm. Microscopic examination revealed adenocarcinoma involving approximately 5% of the total tissue volume, with a Gleason score of 7/10, consisting of primary pattern 3/5 and secondary pattern 4/5. The tumor was present in the left posterior lobe mid region, extending up to the surface of the specimen, and was suspicious for extension beyond the plane of surgical resection. High-grade prostatic intraepithelial neoplasia (PIN) was present. The surgical margin status is suspicious for extension of the neoplasm, and further clinical correlation is recommended.","The prostate gland weighed 67 grams and measured 5.5 x 5.0 x 5.0 cm. Microscopic examination revealed adenocarcinoma involving approximately 5% of the total tissue volume, with a Gleason score of 7/10, consisting of primary pattern 3/5 and secondary pattern 4/5. The tumor extended up to the surface of the specimen, and was suspicious for extension beyond the plane of surgical resection. High-grade prostatic intraepithelial neoplasia (PIN) was present. The surgical margin status is suspicious for extension of the neoplasm, and further clinical correlation is recommended."
TCGA-D5-6898,TCGA-D5-6898.dce0850f-677e-4b31-9d4b-d92d1bfbb41a,"page 1 / 1. Examination: Histopathological examination. Cost of diagnostic procedure. Material: 1. Partial organ resection - sigmoid colon. Material received. Expected time of examination: Clinical diagnosis: Macroscopic description: A 17 cm length of the large intestine with a fragment of the mesentery sized 19 X 6 X 1.5 cm. A cauliflower-shaped. tumour sized 4.3 x 0.6 found in the mucosa. The lesion surrounds 100% of the intestine circumference and narrows its. lumen, is located 7 cm 7 cm away from the other one. The lesion macroscopically infiltrates the intestinal wall. Minimum side margin is 2.3 cm. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa tunicae muscularis priopriae. Excision lines clear of neoplastic infiltration. Lymphonodulitis reactiva lymphonodorum (NO VIII). Histopathology diagnosis: Adenocarcinoma tubulare coli. Tubular adenocarcinoma of the colon. (GI, Dukes A, Astler - Coller Bl, pT2, pNO).","The microscopic description reveals adenocarcinoma tubulare (G2) with infiltration of the muscularis propria. The excision lines are clear of neoplastic infiltration. Lymphonodulitis reactiva lymphonodorum is present, classified as NO VIII. The histopathology diagnosis is adenocarcinoma tubulare coli, a tubular adenocarcinoma of the colon, classified as GI, Dukes A, Astler-Coller B, pT2, and pNO.","The microscopic description reveals adenocarcinoma tubulare (G2) with infiltration of the muscularis propria. The excision lines are clear of neoplastic infiltration. Lymphonodulitis reactiva lymphonodorum is present, classified as N0 VIII. The histopathology diagnosis is adenocarcinoma tubulare coli, a tubular adenocarcinoma of the colon, classified as GI, Dukes A, Astler-Coller B, pT2, and pN0."
TCGA-22-5483,TCGA-22-5483.45ffb097-f0d9-4850-895e-ce7ebef84502,"DIAGNOSIS: Lung, right upper lobe, lung sleeve resection: Invasive grade 4. (of. 4) squamous cell carcinoma forming a 3.3 x 3.0 x 3.0 cm. endobronchial obstructive mass within the upper lobe main bronchus. Obstructive pneumonia is present in the distal lung parenchyma. A. hamartoma (1.0 x 0.8 x 0.7 cm) is also identified. The initial. distal margin is negative for tumor, and the initial proximal margin. shows focal squamous cell carcinoma in situ. After re-excision, no. carcinoma in situ is identified. The separately submitted anterior. lateral margin of the right mainstem bronchus is composed of benign. soft tissue. Lung, right upper lobe, anterior basilar, wedge resection: Scar and. focal organizing pneumonia. Bronchus, right mainstem, biopsy: Bronchial mucosa without. diagnostic abnormalities. Lymph nodes, mediastinal, excision: No tumor is identified in multiple (7) right lower. paratracheal (station 4R) lymph nodes. No tumor is identified in multiple (18) subcarinal. (station 7) lymph nodes. Lymph nodes, intrapulmonary/hilar, excision: Metastatic carcinoma is identified in multiple (2 of 6). intrapulmonary peribronchial lymph nodes. No tumor is identified in a single right hilar (station. 10R) lymph node. No tumor is identified in multiple (2) interlobar. (station 11) lymph nodes.","The pathology report reveals a diagnosis of invasive grade 4 squamous cell carcinoma in a 3.3 x 3.0 x 3.0 cm endobronchial obstructive mass within the right upper lobe main bronchus. The tumor is accompanied by obstructive pneumonia in the distal lung parenchyma and a small hamartoma. The initial distal margin is negative for tumor, but the initial proximal margin shows focal squamous cell carcinoma in situ, which is not present after re-excision. Metastatic carcinoma is identified in multiple intrapulmonary peribronchial lymph nodes, while no tumor is found in the mediastinal, hilar, or interlobar lymph nodes.","The pathology report reveals a diagnosis of invasive grade 4 squamous cell carcinoma in a 3.3 x 3.0 x 3.0 cm endobronchial obstructive mass within the right upper lobe main bronchus. The tumor is accompanied by obstructive pneumonia in the distal lung parenchyma and a small hamartoma. The initial distal margin is negative for tumor, but the initial proximal margin shows focal squamous cell carcinoma in situ, which is not present after re-excision. Metastatic carcinoma is identified in multiple intrapulmonary peribronchial lymph nodes, while no tumor is found in the mediastinal, hilar, or interlobar lymph nodes."
TCGA-95-7944,TCGA-95-7944.567e989f-6896-4faf-84bb-8ef786461228,"Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Histology. APRPT (Verified). Acc #: M. Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LUNG, LEFT LOWER LOBE, WEDGE RESECTION, A1FS: - NON-SMALL CELL CARCINOMA (1.4 X 1.2 X 1.1 CM), FAVOR POORLY DIFFERENTIATED ADENOCARCINOMA. - NO LYMPHOVASCULAR INVASION IDENTIFIED. - MARGINS OF RESECTIONS ARE NEGATIVE. - SEE SYNOPTIC REPORT AND COMMENT. B. LYMPH NODE, #9, EXCISION, B1FS-B2FS: - TWO LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/2). C. LYMPH NODE, #7, EXCISION, C1FS: ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). D. LYMPH NODE, #6, EXCISION, D1FS-D2FS: - THREE LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/3). E. LYMPH NODE, #10L, EXCISION, E1FS: Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. - TWO LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/2). F. LUNG, LEFT LOWER LOBE, EXTENDED WEDGE RESECTION: - LUNG PARENCHYMA NEGATIVE FOR CARCINOMA. Comment. Immunohistochemical stains for TTf-1, p63 and Ck5 are negative. Synoptic Worksheet. B. #9 lymph node: Specimen: Lobe(s) of lung: left lower lobe. Procedure: Wedge resection. Specimen Integrity: Intact. Specimen Laterality: Left. Tumor Site: Lower lobe. Tumor Focality: Unifocal. Histologic Type: Adenocarcinoma. Histologic Grade: G3: Poorly differentiated. Tumor Size: Greatest dimension: 1.4 cm. Additional dimension: 1.2 cm. Additional dimension: 1.1 cm. Visceral Pleura Invasion: Not identified. Tumor Extension: Not identified. Bronchial Margin: Involvement by invasive carcinoma not applicable. Involvement by squamous cell carcinoma in situ (CIS) not applicable. Vascular Margin: Not applicable. Parenchymal Margin: Uninvolved by invasive carcinoma. Parietal Pleural Margin: Not applicable. Chest Wall Margin: Not applicable. Other Attached Tissue Margin: Not applicable. All Margins Uninvolved By Invasive Carcinoma: Distance of invasive carcinoma from closest margin: 39 mm. Margin closest to invasive carcinoma: parenchymal. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or. visceral pleura, without bronchoscopic evidence of invasion more proximal. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. than the lobar bronchus (ie, not in the main bronchus); or Superficial. spreading tumor of any size with its invasive component limited to the. bronchial wall, which may extend proximally to the main bronchus. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Nodes examined: 0. Nodes involved: 8. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: None identified. Clinical History. Left video-assisted thorascopic surgery, wedge resection. Specimen(s) Received. A: Left lower lobe wedge, FS. B: #9 lymph node. C: Lymph node #7. D: Lymph node #6. E: Lymph node #10L. F: Extended wedge, left lower lobe. Gross Description. Six specimens are received fresh for intraoperative consultation, each labeled with the patient's name and medical record. number. Specimen A is further labeled ""left lower lobe wedge."" It consists of a wedge of lung measuring 6.8 x 2.5 x 2.1 cm and weighing. 12.7 grams. The pleural surface has been previously opened to reveal a 1.4 X 1.2 x 1.1 cm firm yellow mass that is 0.3 cm from. the stapled surgical resection margin. The remaining lung parenchyma is unremarkable. A representative section of the mass. and of normal lung is submitted for Tumor Bank. The specimen is inked as follows: pleural surface blue, surgical resection. margin underneath staple line green. A portion of the mass is submitted for intraoperative consultation and transferred to. cassette ""A1FS."" The remaining cassette summary is as follows. Specimen B is labeled as ""#9 lymph node"" and consists of three lymph nodes that measure 1.2 to 2.2 cm in greatest dimension. Two lymph nodes are submitted for intraoperative consultation and transferred to cassette ""B1FS."" One lymph node is submitted. for intraoperative consultation and transferred to cassette ""B2FS."". Specimen C is labeled as ""lymph node #7"" and consists of a fragment of tissue that measures 2.2 x 1.3 x 0.5 cm. One lymph. node is identified. The lymph node is submitted for intraoperative consultation and transferred to cassette ""C1FS."" Additional. tissue is submitted in cassette ""C2."". Specimen D is received fresh for intraoperative consultation and is labeled ""lymph nodes #6."" It consists of three lymph nodes. ranging in size from 0 4 to cm The lumnh nodes are submitted entirely for frozen section diagnosis in cassettes ""D1FS"" and. ""D2FS."". Specimen E is received fresh for intraoperative consultation and is labeled ""lymph nodes #10L.' It consists of two lymph nodes. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures. of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. ranging. in. size. from. 1 0 cm to cm The lymph nodes are submitted entirely for frozen section diagnosis in cassette ""E1FS."". Specimen F is received in formalin and labeled ""extended wedge, left lower lobe."" It consists of a portion of lung measuring 4.0 X. 3.9 x 1.9 cm and weighing 13.0 grams. A ring of stapled margin entirely encircles the specimen. The lung parenchyma is. unremarkable. with no lesions identified. The specimen is inked as follows: resection margin green, pleura blue. Representative. sections are submitted in cassettes ""F1"" through ""F4."". Cassette Summary: A2: Additional mass. A3: Surgical resection margin closest to mass. A4: Uninvolved lung. D1FS: Two lymph nodes, one bisected and one inked blue. D2FS: Lymph node, bisected. Intraoperative Consult Diagnosis. A1FS: LEFT LOWER LOBE WEDGE (FROZEN SECTION): POORLY DIFFERENTIATED CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. and start time. 31FS,B2FS: #9 LYMPH NODE (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. In at. C1FS: LYMPH NODE #7 (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. in. at. D1FS: LYMPH NODE #6 (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. in. at. E1FS: LYMPH NODE #10L (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. in. at. Microscopic Description. Microscopic examination performed. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports.","The patient underwent a left lower lobe wedge resection for a 1.4 x 1.2 x 1.1 cm poorly differentiated adenocarcinoma. The tumor was found to be non-small cell carcinoma, favor poorly differentiated adenocarcinoma, with no lymphovascular invasion identified and negative margins of resection. The tumor was 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal, classified as pT1a. Eight lymph nodes were examined, with no regional lymph node metastasis, classified as pNO. Immunohistochemical stains for TTF-1, p63, and CK5 were negative. Microscopic examination revealed a poorly differentiated adenocarcinoma with no lymph node metastasis identified in lymph nodes #9, #7, #6, and #10L, all negative for metastatic carcinoma.","The patient underwent a left lower lobe wedge resection for a 1.4 x 1.2 x 1.1 cm poorly differentiated adenocarcinoma. The tumor was found to be non-small cell carcinoma, favor poorly differentiated adenocarcinoma, with no lymphovascular invasion identified and negative margins of resection. The tumor was 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal, classified as pT1a. Eight lymph nodes were examined, with no regional lymph node metastasis, classified as pN0. Immunohistochemical stains for TTF-1, p63, and CK5 were negative. Microscopic examination revealed a poorly differentiated adenocarcinoma with no lymph node metastasis identified in lymph nodes #9, #7, #6, and #10L, all negative for metastatic carcinoma."
TCGA-DJ-A13W,TCGA-DJ-A13W.00FB68C5-7946-4E69-9019-4E8BF9EB6A94,"Clinical Diagnosis & history: Left thyroid nodule suspicious for follicular neoplasm on FNA. Specimens Submitted: 1: SP: Para tracheal lymph node. 2: SP: peri thyroidal lymph node. 3: SP: Thyroid, total thyroidectomy. DIAGNOSIS: LYMPH NODE, PARA TRACHEAL; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 2. LYMPH NODE, PERI THYROIDAL; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 3. SP: Thyroid, total thyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentlated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 2.0 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Not identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Clinical Diagnosis & History: Left thyrold nodule suspicious for follicular neoplasm on FNA. Specimens Submitted: 1: SP: Para tracheal lymph node. 2: SP: peri thyroidal lymph node. 3: SP: Thyroid, total thyroldectomy. DIAGNOSIS: 1. LYMPH NODE, PARA TRACHEAL; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 2. LYMPH NODE, PERI THYROIDAL; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 3. SP: Thyroid, total thyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentlated. Mitotic Activity: Not Identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter Is 2.0 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Not identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Papillary microcarcinoma, 0.6cm (right lobe). Non-Neoplastic Thyroid: Exhibits chronic lymphocytic thyroiditis consistent with Hashimoto's thyroiditis. Parathyroid Glands: Not identified. Lymph Nodes: Two benign lymph nodes (0/2). IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT 1 HAVE. REVIEWED AND APPROVED THIS REPORT. Report lectronically Signed Out. Gross Description: 1.) The specimen is received fresh, labeled ""paratracheal lymph node"" and consists of a single pink tan firm lymph node(1.2 x 0.5 x. 0.4 cm). Bisected and entirely submitted. Summary of sections: BLN-- bisected lymph nodes. 2.) The specimen is received fresh, labeled ""perithyroidal lymph node"" and consists of two pink tan firm lymph nodes measuring. 0.8 and 0.5 cm in greatest dimension. Entirely submitted. Summary of sections: LN -- lymph nodes. 3.) The specimen is received fresh, labeled ""total thyroid, stitch marks left superior pole"" and consists of a thyroid weighing 20.5. grams. The right lobe measures 3.5 x 2.4 x 1.5 cm, the left lobe measures 4.5 x 2.8 x 1.8 cm and the isthmus measures 1.2 x 0.6. x 0.6 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the. anterior is inked blue. Sectioning reveals round tan/yellow, well circumscribed mass(2.0 x 1.4 x 1.2 cm) in the lower pole of the. left lobe. Sections through the remaining tissue reveal irregular white firm area in the left upper pole, and 0.6 x 0.6 x 0.5 stellate. white fibrous area in the mid right lobe. The remaining thyrold parenchyma is red tan and meaty. Representative sections of the. specimen are submitted for TPS. The remaining tissue is serially sectioned and entirely submitted. Summary of sections: N - nodule left lobe. RL right lobe. LL left lobe. IS isthmus. Summary of Sections: Part 1: SP: Para tracheal lymph node. Block. Sect. Site. PCs. 1. BLN. 1. Part 2: SP: peri thyroidal lymph node. Block. Sect. Site. PCs. 1. LNS. 1. Part 3: SP: Thyroid, total thyroidectomy. Block. Sect. Site. PCs. 1. IS. 1. 4. LL. 4. 5. N. 5. 6. RL. 6.","The pathology report reveals a diagnosis of papillary carcinoma, follicular variant, in the left lobe of the thyroid gland. The tumor is well-differentiated, with a greatest diameter of 2.0 cm, completely surrounded by a capsule, and no capsular invasion, blood vessel invasion, or extrathyroid extension. The tumor is free of margins. Additionally, a papillary microcarcinoma, measuring 0.6 cm, was found in the right lobe. The lymph nodes, including a para-tracheal lymph node and two peri-thyroidal lymph nodes, were found to be benign. The thyroid tissue also exhibits chronic lymphocytic thyroiditis consistent with Hashimoto's thyroiditis.","The pathology report reveals a diagnosis of papillary carcinoma, follicular variant, in the left lobe of the thyroid gland. The tumor is well-differentiated, with a greatest diameter of 2.0 cm, completely surrounded by a capsule, and no capsular invasion, blood vessel invasion, or extrathyroid extension. The margins are free of tumor. Additionally, a papillary microcarcinoma, measuring 0.6 cm, was found in the right lobe. The lymph nodes, including a para-tracheal lymph node and two peri-thyroidal lymph nodes, were found to be benign. The thyroid tissue also exhibits chronic lymphocytic thyroiditis consistent with Hashimoto's thyroiditis."
TCGA-BJ-A2NA,TCGA-BJ-A2NA.24BC880A-E148-4D78-8C33-5F8FB59258E5,"ADDENDA: Addendum. MOLECULAR ANATOMIC PATHOLOGY TESTING: (thyroid right mid lobe papillary carcinoma 1.5 cm): A. BRAF mutation IDENTIFIED. B. Mutations in NRAS61, HRAS61, KRAS12/13 and RET/PTC1 and RET/PTC3 rearrangements. NOT identified. NOTE: Nucleic acids were extracted in the amount sufficient for testing. FINAL DIAGNOSIS: PART 1: THYROID, TOTAL THYROIDECTOMY (31 GRAMS) -. A. PAPILLARY THYROID CARCINOMA; MULTIFOCAL, BILATERAL, AT LEAST 7 FOCI (RANGE: less than 0.1 TO. 1.5 CM). 8. LARGEST FOCUS: RIGHT MID LOBE, CONVENTIONAL TYPE WITH FOCAL TALL CELL FEATURES (see. comment). 1. ANGIOLYMPHATIC INVASION PRESENT. 2. MICROSCOPIC EXTRATHYROIDAL EXTENSION PRESENT. 3. CARCINOMA FOCALLY EXTENDS TO THE SURGICAL MARGIN. 4. PATHOLOGIC STAGE: pT3 NO. C. ONE (1) LYMPH NODE, NO TUMOR PRESENT (0/1). D. ONCOCYTIC FOLLICULAR (HRTHLE CELL) ADENOMA (2.5 CM), RIGHT LOBE. E. CHRONIC LYMPHOCYTIC THYROIDITIS AND NODULAR HYPERPLASIA. PART 2: CENTRAL COMPARTMENT CONTENTS, EXCISION -. A. ONE (1) NORMOCELLULAR PARATHYROID GLAND. B. UNREMARKABLE THYMIC TISSUE. c. NO LYMPH NODES PRESENT. D. TISSUE ENTIRELY SUBMITTED FOR HISTOLOGIC EVALUATION. COMMENT: Molecular studies will be performed and the results will be reported as an addendum. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe, Left Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 1.5 cm. HISTOLOGIC TYPE: Papiliary carcinoma. PRIMARY TUMOR (pT): pT3. REGIONAL LYMPH NODES (pN): pNO. Number of regional lymph nodes examined: 1. Number of regional lymph nodes involved: 0. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Present. Extent: Minimal. MARGINS: Margin(s) involved by carcinoma. LYMPH-VASCULAR INVASION: Not identified. ADDITIONAL PATHOLOGIC FINDINGS: Adenoma. Thyroiditis.","The patient underwent a total thyroidectomy with the final diagnosis of multifocal, bilateral papillary thyroid carcinoma. The carcinoma was identified in at least 7 foci, ranging from less than 0.1 to 1.5 cm in size, with the largest focus being 1.5 cm in the right mid lobe. The carcinoma showed conventional type with focal tall cell features, angiolymphatic invasion, microscopic extrathyroidal extension, and carcinoma extending to the surgical margin. Molecular testing revealed a BRAF mutation, but no mutations in NRAS61, HRAS61, KRAS12/13, or RET/PTC1 and RET/PTC3 rearrangements. One lymph node was examined, and no tumor was present. Additionally, an oncocytic follicular (Hrthle cell) adenoma was identified in the right lobe, and chronic lymphocytic thyroiditis and nodular hyperplasia were also present.","The patient underwent a total thyroidectomy with the final diagnosis of multifocal, bilateral papillary thyroid carcinoma. The carcinoma was identified in at least 7 foci, ranging from less than 0.1 to 1.5 cm in size, with the largest focus being 1.5 cm in the right mid lobe. The carcinoma showed conventional type with focal tall cell features, angiolymphatic invasion, microscopic extrathyroidal extension, and carcinoma extending to the surgical margin. Molecular testing revealed a BRAF mutation, but no mutations in NRAS61, HRAS61, KRAS12/13, or RET/PTC1 and RET/PTC3. One lymph node was examined, and no tumor was present. Additionally, an oncocytic follicular (Hurthle cell) adenoma was identified in the right lobe, and chronic lymphocytic thyroiditis and nodular hyperplasia were also present."
TCGA-D8-A1XG,TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E,"page 1 / 1. copy No. Examination: Histopathological examination. Gender: F. Material: 1. Total organ resection - right breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the right breast, ulcerous - Toilet mastectomy. Macroscopic description: Right breast Sized 13.7 x 7.6 x 4.8 cm removed without axillary tissues and with a skin flap of 17.8 x 10.2 cm. Weight 193 g. Tumour sized 6.2 x 4.3 x 7.8 cm in the middle part, 0.1 cm from the upper boundary, 0.1 cm from the base. Microscopic description: Carcinoma ductale invasivum - NHG3 (3+2+3/20 mitoses/10 HPF - visual area: 0.55mm). Infiltratio carcinomatosa cutis et musculi pectoralis. Mamilla sine laesionibus. Glandular tissue showing parenchyma atrophy. Histopathological diagnosis: Carcinoma ductale invasivum mammae dextrae. Invasive ductal carcinoma of the right breast. Metastases carcinomatosae in lymphonodis axillae (No II/II). Cancer metastases of the axillary lymph nodes. (NHG3, pT4b, pN1a). Results of immunohistochemical examination: Estrogen receptors found in 10-75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of. neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Negative reaction in invasive cancerous cells ( Score = 0). Compliance valida.","The patient is a female who underwent a total organ resection of the right breast due to a clinical diagnosis of ulcerous cancer. The microscopic examination revealed invasive ductal carcinoma of the right breast (NHG3) with 3+2+3/20 mitoses/10 HPF and a visual area of 0.55mm. The cancer had infiltrated the skin and pectoral muscle, but the nipple was without lesions. The glandular tissue showed parenchyma atrophy. Immunohistochemical examination showed estrogen receptors in 10-75% of neoplastic cell nuclei, progesterone receptors in 10-75% of neoplastic cell nuclei, and a negative reaction for HER2 protein in invasive cancerous cells. The cancer had metastasized to the axillary lymph nodes (No II/II), classified as pT4b, pN1a.","The patient is a female who underwent a total organ resection of the right breast due to a clinical diagnosis of ulcerous cancer. The microscopic examination revealed invasive ductal carcinoma of the right breast (NHG3) with 3+2+3/20 mitoses/10 HPF within a visual area of 0.55mm. The cancer had infiltrated the skin and pectoral muscle, but the nipple was without lesions. The glandular tissue showed parenchyma atrophy. Immunohistochemical examination showed estrogen receptors in 10-75% of neoplastic cell nuclei, progesterone receptors in 10-75% of neoplastic cell nuclei, and a negative reaction for HER2 protein in invasive cancerous cells. The cancer had metastasized to the axillary lymph nodes, classified as pT4b, pN1a."
TCGA-OR-A5K5,TCGA-OR-A5K5.6EA3FB77-3DD4-43C8-8C39-CA8755EBC50C,"PREVIOUS DIAGMOSIS INOUTRY. 2. SEX: F. BIRTHDATE: ADM DATE: OPER DATE: PROCEDURE: SPHS. Patient with left adrenal mass. PROCEDURE: SPGD. 1. ""L adrenal mass"" Received fresh for frozen section is a fully-encapsulated,. 447 gram, excision specimen (up to 14.5 cm x up to 9.5 cm x up to 6 cm). Inked. green on its entire exterior capsule and bivalved to reveal an interior,. mottled red-brown and orange, with areas highly suspicious for necrosis. Sampled for frozen section analysis and extensively for tissue procurement. Extensively sectioned to reveal scant extratumoral adipose, no attached Lymph. nodes, and no identifiable uninvolved adrenal tissue. Gross estimation of. necrotic tumor mass approximately 30%. 1A. Frozen section control. 1B-c. Large central sections of Lesion. 1D-K. Additional sections showing full range of gross morphology of the Lesion. and sampling margins from which it is grossly free. greater than one. section per cm of tumor). 2. ""Left periaortic lymph node packet"" Received in formalin in a small. container is a lymphadenectomy specimen (4 x 3 x 2 cm). Serially sectioned to. reveal multiple small Lymph node candidates. 2A-D. ,. candidates, small amount of adipose tissue). 3. ""Left suprarenal periaortic lymph nodes"" Received in formalin in a small. container is a lymphadenectomy specimen (2 x 2 x 0.6 cm). Dissected, the. specimen appears to consist predominantly of vascular tissue. Submitted. entirely in cassette 3A. PREVIOUS DIAGNOSIS INQUIRY. 3. SEX: F. ADM DATE: BIRTHDATE: OPER DATE: FROZEN SECTION REPORT. 1. Positive for carcinoma. Frozen section diagnosis is confirmed. PROCEDURE: SPMI. ADRENOCORTICAL CARCINOMA. Tumor Size: 14.5 x 9.5 x 6 cm. Tumor Weight: 447 grams. Capsular Invasion: Yes. Vascular Invasion: Yes. Surgical Margins: Negative but close. Necrosis: Mitotic Rate: 31 mitoses / 50 high power fields. Grade: High. Lymph nodes status: Negative (0/20). Extra-adrenal extension: Yes, focal. Stage: III (extra-adrenal extension). Immunchistochemistry Results: NA. PROCEDURE: SPDX. 1. Left adrenal gland, resection: Adrenocortical carcinoma, high-grade by. mitotic rate, margins negative but close. See Template. PREVIOUS DIAGNOSIS INQUIRY. SEX: F. BIRTHDATE: ADM DATE: OPER DATE: 2. Lymph node, left periaortic, excision: Twenty lymph nodes negative for. carcinoma (0/20). 3. Soft tissue, left suprarenal, excision: Ganglion and fibrovascular tissue,. negative for carcinoma. the signing staff pathologist, have. personally examined and interpreted the slides from this case. END OF PREVIOUS DIAGNOSIS INQUIRY.","The patient is a female with a left adrenal mass. The frozen section analysis revealed a fully-encapsulated, 447-gram, 14.5 x 9.5 x 6 cm adrenocortical carcinoma with a high mitotic rate of 31 mitoses per 50 high power fields, indicating a high-grade tumor. The tumor showed capsular invasion, vascular invasion, and focal extra-adrenal extension, with a stage of III. The surgical margins were negative but close. The lymph nodes examined were negative for carcinoma, with 20 lymph nodes showing no evidence of cancer. The microscopic description revealed a mottled red-brown and orange interior with areas highly suspicious for necrosis, and scant extratumoral adipose tissue with no attached lymph nodes or identifiable uninvolved adrenal tissue.","The patient is a female with a left adrenal mass. The frozen section analysis revealed a fully-encapsulated, 447-gram, 14.5 x 9.5 x 6 cm adrenocortical carcinoma with a high mitotic rate of 31 mitoses per 50 high power fields, indicating a high-grade tumor. The tumor showed capsular invasion, vascular invasion, and focal extra-adrenal extension, with a stage of III. The surgical margins were negative but close. The lymph nodes examined were negative for carcinoma, with 20 lymph nodes showing no evidence of cancer. The microscopic description revealed a mottled red-brown and orange interior with areas highly suspicious for necrosis, and scant extratumoral adipose tissue with no attached lymph nodes or identifiable uninvolved adrenal tissue."
TCGA-A2-A0T0,TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096,"SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Account Number. Doctor: PRE-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. PROCEDURE. LEFT BREAST LUMPECTOMY WITH AXILLARY LYMPH NODE DISSECTION. TISSUES. A. BREAST EXCISION NEEDLE LOC, SIMPLE, MARGINS,ETC - LEFT. B. AXILLARY - CONTENTS LEFT. C. AXILLARY - ADDITIONAL CONTENTS LEFT. D. MARGINS - ADDITIONAL LATERAL. E. MARGINS - ADDITIONAL MEDIAL. ADDENDUM 2. HER-2 (IHC) -. o. NOT AMPLIFIED. SPECIAL STAINS PERFORMED: Her-2 (IHC) (HA). Revlewed and electronically signed out by: ADDENDUM. ESTROGEN AND PROGESTERONE RECEPTOR RESULTS: ESTROGEN RECEPTORS -. NEGATIVE IN THE MALIGNANT CELLS (0%). PROGESTERONE RECEPTORS- -. NEGATIVE IN THE MALIGNANT CELLS (0%). Comment: The control tissues for Estrogen and Progesterone Receptor. Immunohistochemical Studies display appropriate staining pattern. 3. SURGICAL REPORT. FS DIAGNOSIS. A. LEFT BREAST LUMP (GROSS MARGINS) -. PORTION OF BREAST TISSUE WITH TUMOR (3.2 X 3.1 X 3.0 CM.) EXTENDING TO. LATERAL SURGICAL MARGIN AND WITHIN 0.1 CM. OF THE MEDIAL SURGICAL. MARGINS. ALL OF THE REMAINING DESIGNATED SURGICAL MARGINS ARE WITHIN 0.6 CM. OF THE TUMOR (GROSS). (REPORTED TO SURGEON: Diagnosed by: FINAL DIAGNOSIS. A. LEFT BREAST LUMP -. BREAST TISSUE DISPLAYING INVASIVE POORLY DIFFERENTIATED DUCTAL. ADENOCARCINOMA OF THE BREAST, 3+3+3, 3.2 CM. IN GREATEST DIMENSION. TUMOR EMBOLI SEEN IN ANGIOLYMPHATIC SPACES. MARGINS ARE FREE. THE NEAREST MARGIN IS 0.1 CM. TO THE TUMOR AS REPORTED IN THE GROSS. EXAMINATION. B. AXILLARY CONTENTS LEFT -. LYMPH NODE, METASTATIC DUCTAL ADENOCARCINOMA IN TWO LYMPH. NODES FROM A TOTAL OF TWELVE LYMPH NODES (2/12). THE LARGEST NODE WITH TUMOR IS 1 CM. IN GREATEST DIMENSION. THE TUMOR TOTALLY OCCUPIES THE NODE WITH EXTRACAPSULAR. EXTENSION TO THE FAT. C. ADDITIONAL AXILLARY CONTENTS, LEFT -. LYMPH NODES, TWO REACTIVE. D. ADDITIONAL LATERAL MARGINS -. FIBROADIPOSE TISSUE AND BREAST TISSUE, NO TUMOR SEEN; HOWEVER, THERE IS. MICROSCOPIC FOCUS OF TUMOR EMBOLI SEEN IN ANGIOLYMPHATIC SPACES. E. ADDITIONAL MEDIAL MARGINS- -. FIBROADIPOSE TISSUE AND BREAST TISSUE, NO TUMOR SEEN. PTNM CLASSIFICATION: T2 N1 MX, STAGE IIB, DUCTAL ADENOCARCINOMA, G3. PQRI CATEGORY II: 3260F. Diagnosed by: /. COMMENT. This case is discussed with. SURGICAL REPORT. GROSS DESCRIPTION. The specimen is received in five separate containers labeled. designated A. through E. A. The container is received fresh unfixed labeled ""left breast lump"" and consists of a 30 gm. ovoid. mass of apparent fatty and fibrous-encased tissue which is 4.5 x 3.5 x 2.8 cm. in greatest overall. dimension. There is a single short suture indicating superior margin inked with orange, inferior. is. inked red. There is a single long suture indicating lateral margin inked with black dye, medial. is. inked blue. There are two short sutures indicating anterior margin inked with green dye, deep. is. inked yellow. Sectioning reveals a tumor, a gray-white irregular bordered tumor which is 3.2 x 3.1. x 3 cm. in greatest overall dimension and has scattered yellow-tan chalky areas varying up to 0.3. cm. in greatest dimension and a central 0.4 cm. slightly gelatinous hemorrhagic area. The tumor. mass grossly appears to involve the lateral/black margin is 0.1 cm. from the medial/blue, 0.5 cm. from the anterior/green, 0.5 cm. from the deep/yellow, 0.5 cm. from the superior/orange and 0.5. cm. from the inferior/red. Gross margins are obtained by Dr. The entire specimen is. submitted in seventeen blocks. Key Note Block Summary: 1-lateral/black, 2-medial/blue, 3-anterior/green, 4. deep/yellow, 5-superior/orange, 6-inferior/red (all are perpendicular), 7 through 17-remaining. B. The container is received fixed labeled ""left axillary contents"" and consists of an irregular mass of. apparent fat 3.5 x 3 x 2.5 cm. Sectioning reveals pink-tan nodules varying up to 2 cm. in greatest. dimension. The larger nodes are hemisected and placed in cassettes 2 through 5. C. The container is received fixed labeled ""additional axillary contents"" and consists of an irregular. mass of apparent fatty tissue which is 1 x 0.6 x 0.4 cm. Sectioning reveals a 0.4 cm. pink-tan. nodule. The entire specimen is submitted as one section in one block. D. The container is received fresh unfixed labeled ""additional lateral margin"" and consists of an 8. gm. ovoid mass of apparent fatty and fibrous encased tissue is 3 x 2.5 x 2 cm. in greatest overall. dimension. There is an attached suture indicating new lateral margin inked with red dye. Sectioning reveals fat and a scant amount of fibrous tissue. The entire specimen is submitted in. four blocks. E. The container is received fresh unfixed labeled ""additional medial margin - suture on new medial. margin"" and consists of an 8 gm. ovoid mass of apparent fatty and fibrous encased tissue is 3 x. 3. x 2.5 cm. in greatest overall dimension. There is a suture indicating new medial margin inked. with blue dye. The entire specimen is submitted in four blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.","The patient is a female with a preoperative diagnosis of left breast cancer. The postoperative diagnosis is also left breast cancer. The patient underwent a left breast lumpectomy with axillary lymph node dissection. The microscopic examination confirms invasive poorly differentiated ductal adenocarcinoma of the breast, 3+3+3, 3.2 cm in greatest dimension. The tumor emboli are seen in angiolymphatic spaces. The margins are free, with the nearest margin being 0.1 cm to the tumor. Two lymph nodes out of twelve examined are metastatic with ductal adenocarcinoma. The estrogen receptors are negative in the malignant cells (0%), and progesterone receptors are also negative in the malignant cells (0%). The HER-2 (IHC) is not amplified. The PTNM classification is T2 N1 MX, Stage IIB, ductal adenocarcinoma, G3. The PQRI category is 3260F.","The patient is a female with a preoperative diagnosis of left breast cancer. The postoperative diagnosis is also left breast cancer. The patient underwent a left breast lumpectomy with axillary lymph node dissection. The microscopic examination confirms invasive poorly differentiated ductal adenocarcinoma of the breast, 3+3+3, 3.2 cm in greatest dimension. The tumor emboli are seen in angiolymphatic spaces. The margins are free, with the nearest margin being 0.1 cm to the tumor. Two lymph nodes out of twelve examined are metastatic with ductal adenocarcinoma. The estrogen receptors are negative in the malignant cells (0%), and progesterone receptors are also negative in the malignant cells (0%). The HER-2 (IHC) is not amplified. The PTNM classification is T2 N1 MX, Stage IIB, ductal adenocarcinoma, G3. The PQRI category is 3260F."
TCGA-AO-A1KQ,TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103,"Clinical Diagnosis & History: y/o male with left breast cancer (invasive ductal carcinoma (IDC)). Specimens Submitted: 1: SP: Sentinel node #1, level 1, left axilla (fs). 2: SP: Left breast with levels one and two axillary contents. DIAGNOSIS: 1). LYMPH NODE, LEFT AXILLA, SENTINEL LYMPH NODE #1; LEVEL 1; BIOPSY: METASTATIC CARCINOMA IN ONE LYMPH NODE (1/1). - THE METASTATIC DEPOSIT IS SEEN ONLY ON THE ACTUAL FROZEN SECTION AND. MEASURES AT LEAST. 2 MM. NO EXTRANODAL EXTENSION IDENTIFIED. - THE LYMPH NODE EXHIBITS INCIDENTAL BENIGN CAPSULAR NEVUS CELL. AGGREGATES. 2). BREAST. LEET: MASTECTOMY: - INVASIVE DUCTAL CARCINOMA. NOS TYPE. HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION), NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND. SHAPE) MEASURING 2.2 CM IN LARGEST DIMENSION MICROSCOPICALLY. - DUCTAL CARCINOMA IN-SITU (DCIS) IS ALSO IDENTIFIED, SOLID, CRIBRIFORM TYPE. WITH HIGH NUCLEAR GRADE AND MODERATE NECROSIS. - THE DCIS CONSTITUTES <= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE LOWER INNER QUADRANT AND CENTRAL. AREA (RETROAREOLAR). - THE NIPPLE IS INVOLVED BY INVASIVE CARCINOMA. - A FOCUS OF PERINEURAL INVASION BY CARCINOMA IS SEEN IN THE DERMIS OF. THE NIPPLE REGION. THERE IS ALSO FOCAL LYMPHATIC INVASION IN THE NIPPLE. REGION. - CALCIFICATIONS ARE PRESENT IN THE IN SITU CARCINOMA. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. THE ION-NEOPLASTIC BREAST TISSUE IS UNRENORKAELE. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF. POSITIVE LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES. EXAMINED) : METASTATIC CARCINONA IN ONE OF EIGHT LYMPH NODES (1/8). THIS IS A MACROMETASTASIS (1.8 CM). - THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. Nc. - RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL BE REPORTED AS AN. ADDENDUM. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. ER-C. PR-C. HER2-0. NEG CONT. NEG-HER2. IMM RECUT. Gross Description: 1) The specimen is received fresh for frozen section consultation labeled,. Sentinel node #1, level 1, left axilla"", and consists of one lymph node. measuring 1.5 x 1.0 x 0.8 cm. The lymph node is bisected and submitted for. frozen section diagnosis. Summary sections: FSC - frozen section control. 2) The specimen is received fresh labeled, ""Left breast with levels one and. two axillary contents, stitch marks axillary tail"" and consists of a breast. measuring 19 x 18 x 3.5 cm with overlying skin ellipse measuring 19 x 11 cm,. attached axillary contents measuring 11 x 10 x 3 cm. The axillary tail is. marked with a black suture. Situated centrally on the skin surface is. a. flattened nipple measuring 0.8 x 0.8 em and areola measuring 2.5 x 2.5 cm. There are no scars or lesions noted on the skin. A suture demarcates the. axillary aspect. The posterior surface of the breast is inked black and the. specimen is serially sectioned to reveal a well circumscribed stony hard. white-tan tumor measuring 2.0 x 2.0 x 1.7 cm, and located 1.8 cm from the. deep margin. The tumor is located subjacent to the nipple The remainder. of. the breast tissue is yellow tan fatty and lobulated. The specimen is. submitted for lymph node dissection. Representative sections are submitted. A sample of the tumor is given to. Summary of sections: N nipple. NB - nipple base. DM - deep margin. T - tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LN-lymph nodes. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: SP: Left breast with levels one and two axillary contents. Block. Sect. Site. PCs. 1. dm. 1. 1. lig. 1. 5. LN. 8. 1. log. 1. 1. n. 1. 1. nb. 1. 6. 6. 1. uiq. 1. uog. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. ADDEN. SITK: #2, LEFT BREAST. ER: >95% OF NUCLEAR STAINING WITH STRONG INTENSITY. - PR: >80% OF NUCLEAR STAINING WITH STRONG TO NODERATE INTENSITY. - HER-2/NEU. (Hexcep Test) : NEGATIVE (STAINING INTENSITY OF FOCAL 1+). - CONTROLS ARZ SATISFACTORY. Intracperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME.","A 40-year-old male with left breast cancer (invasive ductal carcinoma) underwent a mastectomy. The pathology report reveals that the invasive ductal carcinoma is of no specific type, histologic grade III/III, and nuclear grade III/III, measuring 2.2 cm in the largest dimension. The carcinoma is located in the lower inner quadrant and central area (retroareolar) of the breast, involving the nipple, with a focus of perineural invasion by carcinoma in the dermis of the nipple region and focal lymphatic invasion in the nipple region. Ductal carcinoma in situ (DCIS) is also identified, solid, cribiform type, with high nuclear grade and moderate necrosis, constituting less than 25% of the total tumor mass. The lymph node status is 1/8, with a macrometastasis of 1.8 cm, and no extranodal extension of carcinoma. Special studies show estrogen receptor (ER) positivity (>95% of nuclear staining with strong intensity), progesterone receptor (PR) positivity (>80% of nuclear staining with strong to moderate intensity), and HER2-neu negativity.","A male patient with left breast cancer (invasive ductal carcinoma) underwent a mastectomy. The pathology report reveals that the invasive ductal carcinoma is of not otherwise specified, histologic grade III/III, and nuclear grade III/III, measuring 2.2 cm in the largest dimension. The carcinoma is located in the lower inner quadrant and central area (retroareolar) of the breast, involving the nipple, with a focus of perineural invasion by carcinoma in the dermis of the nipple region and focal lymphatic invasion in the nipple region. Ductal carcinoma in situ (DCIS) is also identified, solid, cribiform type, with high nuclear grade and moderate necrosis, constituting less than 25% of the total tumor mass. The lymph node status is 1/8, with a macrometastasis of 1.8 cm, and no extranodal extension of carcinoma. Special studies show estrogen receptor (ER) positivity (>95% of nuclear staining with strong intensity), progesterone receptor (PR) positivity (>80% of nuclear staining with strong to moderate intensity), and HER2-neu negativity."
TCGA-DU-7301,TCGA-DU-7301.8ff62d9f-003f-4194-8cc6-bce45a7cdf1d,"Physician (s) : Phy Locat. CLINICAL HISTORY. Not Given. OPERATIVE DIAGNOSES. Not Given. Operation/Specimen: A: Brain, Left posterior frontal, excision biopsy. B: Brain, enhanced parts of tumor, excision biopsy. PATHOLOGICAL DIAGNOSIS: A, B C, Brain, left posterior frontal, tumor resection: Oligodendroglioma, MIB-1 : about 4%. COMMENT. This tumor is an oligodendroglioma with a microcystic loose. background. Nuclear atypia is mild and mitosis is not found. There is no vascular hyperplasia nor necrosis. PROCEDURES/ADDENDA. MGMT Promoter Methylation. Interpretation. NEGATIVE - No evidence of methylated MGMT promoter is detected. Results-Comments. Received paraffin sections labeled dated. TEST DESCRIPTION: Bisulfite treatment of DNA followed by PCR. amplification of. both methylated and unmethylated MGMT promoter sequences, with. products. detected by gel electrophoresis. FDA COMMENT: The above data are not to be construed as the results. from a. stand-alone diagnostic test. This test was developed and its. performance. characteristics determined by the AP Molecular Pathology laboratory as. required by. regulations. It has not been cleared or approved. for. specific uses by the U.S. Food and Drug Administration (FDA) The FDA. has. determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted. only in. the context of established procedures and/or diagnostic criteria. INTRA-OPERATIVE CONSULTATION. Brain, Left posterior frontal, excision biopsy: Glioma, 1 block,. Senior Staff Pathologist. GROSS DESCRIPTION. A. Multiple tissue fragments, 0.2 to 0.5 cm, all in A1, A2. B. SPECIMEN: Enhanced part of tumor. FIXATIVE: None. GENERAL: Received are multiple pink-tan, glistening fragments of soft. tissue,. 2.0 x 1.7 x 0.2 cm in aggregate. SECTIONS: Entirely submitted in B1. ICD-9 (s) : 191.9 191.9. Histo Data. Part A: Brain, Left posterior frontal, excision biopsy. Stain/cnt. Block. Comment. H/E X 1. 1. X 1. 1. H/E X 1. 2. FS H/E x 1. (none). Part B: Brain, enhanced parts of tumor, excision biopsy. Stain/cnt. Block. Comment. mGFAP-DA x 1. 1. H/E X 1. 1. MGMT x 1. 1. MIB1-DA x 1. 1.","The pathology report indicates that the patient underwent an excision biopsy of a brain tumor in the left posterior frontal region. Microscopic examination revealed an oligodendroglioma with a microcystic, loose background. The tumor showed mild nuclear atypia and no mitosis, vascular hyperplasia, or necrosis. The MIB-1 proliferation index was about 4%. The MGMT promoter methylation status was negative, indicating no evidence of methylated MGMT promoter. The tumor was stained with H&E, GFAP-DA, MGMT, and MIB1-DA, with results available for all stains.","The pathology report indicates that the patient underwent an excision biopsy of a brain tumor in the left posterior frontal region. Microscopic examination revealed an oligodendroglioma with a microcystic, loose background. The tumor showed mild nuclear atypia and no mitosis, vascular hyperplasia, or necrosis. The MIB-1 proliferation index was about 4%. The MGMT promoter methylation status was negative, indicating no evidence of methylated MGMT promoter. The tumor was stained with H&E, GFAP-DA, MGMT, and MIB1-DA, with results available for all stains."
TCGA-HT-A617,TCGA-HT-A617.0DF6A8BE-1AE0-40CE-98D1-5B17DCB44FE7,"Addendum Discussion. The calculated MIB-1 labeling index is 3.0% consistent with a low grade oligodendroglioma. Addendum Diagnosis: Right Insular Tumor, including enhancing region. Oliogodendroglioma (who grade II). MIB-1 LI= 3.0%. Microscopic Description: Sections demonstrate gray and white matter that is diffusely infiltrated by a mildly to moderately. hypercellular glial neoplasm. The majority of the tumor cells have round nuclei with only mild atypia. Perinuclear halos are prominent in most. A minority component is a fibrillary astrocytoma phenotype or. a gemistocytic phenotype. In these sections, no mitosis are seen and there is no microvascular. proliferation or necrosis. A neo plastic ganglion cell component is not seen. Eosinophilic granular bodies. are not identified.","The microscopic description of the tumor reveals a mildly to moderately hypercellular glial neoplasm diffusely infiltrating gray and white matter, with the majority of tumor cells having round nuclei and mild atypia, and prominent perinuclear halos. A minority component shows a fibrillary astrocytoma or gemistocytic phenotype. No mitosis, microvascular proliferation, necrosis, or neoplastic ganglion cell component is observed. Eosinophilic granular bodies are also not identified. The calculated MIB-1 labeling index is 3.0%, consistent with a low-grade oligodendroglioma. The diagnosis is oligodendroglioma (WHO grade II) with a MIB-1 LI of 3.0%.","The microscopic description of the tumor reveals a mildly to moderately hypercellular glial neoplasm diffusely infiltrating gray and white matter, with the majority of tumor cells having round nuclei and mild atypia, and prominent perinuclear halos. A minority component shows a fibrillary astrocytoma or gemistocytic phenotype. No mitosis, microvascular proliferation, necrosis, or neoplastic ganglion cell component is observed. Eosinophilic granular bodies are also not identified. The calculated MIB-1 labeling index is 3.0%, consistent with a low-grade oligodendroglioma. The diagnosis is oligodendroglioma (WHO grade II) with a MIB-1 LI of 3.0%."
TCGA-ZN-A9VO,TCGA-ZN-A9VO.D10B7DE3-1AE6-42A3-BC9A-53CECC84BD96,"Report Status: Final. Procedure Date: PATHOLOGIC DIAGNOSIS: A. PORT SITE 1: Skin, subcutaneous soft tissue, and skeletal muscle with scar and f. foreign body giant cell reaction. There is no evidence of malignancy. B. RIB: Bone marrow with maturing trilineage hematopoiesis. There is no evidence of malignancy. C. LEVEL 9: One (1) lymph node, negative for tumor. D. LEVEL 8: One (1) lymph node, negative for tumor. E. RIGHT LUNG, DIAPHRAGM, PERIOTENUM, PERICARDIUM, (INCLUDING FSA) : DIFFUSE MALIGNANT MESOTHELIOMA, EPITHELIOID TYPE. Tumor involves chest wall parietal pleura, maximal thickness of 4cm and. mediastinal pleura and diaphragmatic pleura. Tumor involves visceral pleura. Visceral pleural involvement by tumor is confluent and includes an interlobar. fissure. Tumor invades lung parenchyma through the diaphragm to the peritoneum. does NOT extend to the inner surface of the pericardium. Tumor is present at all resection margins. Lymphovascular invasion is not identified. ""Diaphragmatic"" LYMPH NODES: Metastatic mesothelioma present in 1 of 1 lymph node (s) . ""Intraparenchymal"" LYMPH NODES: Metastatic mesothelioma present in 0 of 2 lymph node (s) . AJCC Classification (7th edition) : ypT4N2M1 (including all parts) . NOTE: The tumor is present at the bronchial resection margin on the frozen section. slide, but not the permanent slide. F. OMENTAL BIOPSY (INCLUDING FSB) : MALIGNANT MESOTHELIOMA, epithelioid type, involving fibroadipose tissue. G. LEVEL 7: Two (2) lymph nodes, negative for tumor. H. 4R: METASTATIC MALIGNANT MESOTHELIOMA, epithelioid type, involving two (2) lymph. nodes. I. OMENTUM: MALIGNANT MESOTHELIOMA, epithelioid type, involving fibroadipose tissue. J. CHEST WALL: Page: 1 of 4. MALIGNANT MESOTHELIOMA, epithelioid type, involving fibroadipose tissue and. skeletal muscle. K. PORT SITE 2: Skin, subcutaneous soft tissue and skeletal muscle with scar, foreign body. giant cell reaction and chronic inflammation. There is no evidence of malignancy. TISSUE SUBMITTED: A/1. Port site #1. B/2. Rib. C/3. Level 9. D/4. Level 8. E/5. Right lung, diaphragm, peritoneum, pericardium. F/6. Omental biopsy (FS). G/7. Level 7. H/8. 4R. I/9. Omentum. J/10. Chest wall. K/11. Port site #2. O.R. CONSULTATION: SPECIMEN LABELED ""5. RIGHT LUNG, DIAPHRAGM, PERITONEUM, PERICARDIUM"" (FSA) : Epithelioid malignant mesothelioma present in small nests in bronchial. resection margin soft tissue. SPECIMEN LABELED ""6. OMENTAL BX"" (FSB) : Metastatic malignant mesothelioma. The senior physician certifies that he/she personally conducted a gross and/or. microscopic examination of the described specimen (s) and rendered or confirmed. the rapid diagnos (es) related thereto. GROSS DESCRIPTION: The specimen is received fresh, in eleven parts, each labeled with the. patient's name and medical record number. Part A, ""#1. Port site #1"", consists of multiple soft tissue fragments (4.6 x. 4.5 x 1.6 cm) consisting of skin (3.2 x 0.7 cm) with underlying soft tissue up. to a depth of 4.4 cm. There are no masses or lesions identified. Micro A1: Skin with underlying soft tissue, 3 frags,. Micro A2: Soft tissue fragments, 3 frags,. Part B, ""#2. Rib"", consists of two segments of rib (12.8 x 1.5 x 0.9 cm, 6.4 x. 1.6 x 0.9 cm) with scant attached fragments of red/brown ragged skeletal. muscle. A rib bone marrow squeeze is submitted for histologic examination. Micro B1: Rib bone marrow squeeze, multi frags,. Part C, ""#3. Level 9"", consists of two tan/pink/brown soft tissue fragments. (1.2 X 0.9 x 0.6 cm in aggregate) The specimen is entirely submitted for. histologic examination. Micro C1: Soft tissue fragments, 2 frags,. Part D, ""#4. Level 8"", consists of a tan/pink soft tissue fragment (1.5 x 1.5. x. 0.8 cm). The specimen is entirely submitted for histologic examination. Page: 2 of 4. Micro D1: Soft tissue fragment, bisected, 2 frags,. Part E, ""#5. Right lung, diaphragm, peritoneum, pericardium"", consists of a. 750-gram right extrapleural pneumonectomy specimen (23 x 17.3 x 4 cm) including. lung (20 x 11.1 x 6.5 cm), open bronchial resection margin (2.3 cm in length x. 1.8 cm in diameter), parietal pleura, pericardium (14 x 7.4 cm) and. hemidiaphragm (31.8 x 19.5 x 11 cm) . The parietal pleura contains greater than. a hundred tan/white nodules (up to 4 cm in greatest dimension), is disrupted,. and adherent only to the apex of the lung. All parietal pleural disruption. margins are positive for tumor. The visceral pleura contains greater than two. hundred tan/white surface nodules (up to 1.8 cm in greatest dimension) that are. present on all lobes. The hemidiaphragm is disrupted and connected only to the. anterior parietal pleura. Both surfaces of the hemidiaphragm are covered by. greater than one hundred tan/white surface nodules (up to 10 cm in greatest. dimension) All diaphragmatic margins are grossly positive for tumor. The. bronchial margin is grossly free of tumor and entirely frozen en face for. frozen section analysis as FSA. The pericardium contains three full thickness. tan/white nodules (up to 2.4 cm in greatest dimension) . The tumor extends into. the lung parenchyma in the lower lobe and thickens the entire length of all of. the intralobular septae. The uninvolved lung parenchyma shows mild. emphysematous changes. Gross photographs are taken. Micro E1: Bronchial resection margin, FSA remnant, 1 frag, ESS. Micro E2: Apical parietal pleural margin, 1 frag, RSS. Micro E3: Medial parietal pleural margin, 1 frag, RSS. Micro E4: Lateral parietal pleural margin, 1 frag, RSS. Micro E5: Anterior parietal pleural margin, 1 frag, RSS. Micro E6: Posterior parietal pleural margin, 1 frag, RSS. Micro E7: Medial diaphragm margin, 1 frag, RSS. Micro E8: Lateral diaphragm margin, 1 frag, RSS. Micro E9: Anterior diaphragm margin, 1 frag, RSS. Micro E10: Posterior diaphragm margin, 1 frag, RSS. Micro E11: Diaphragm and tumor, full thickness section, 1 frag, RSS. Micro E12: Tumor and interlobar septae, 1 frag, RSS. Micro E13: Tumor with extension into lung parenchyma, 2 frags, RSS. Micro E14: Upper lobe, uninvolved parenchyma, 1 frag, RSS. Micro E15: Middle lobe, uninvolved parenchyma, 1 frag, RSS. Micro E16: Lower lobe, uninvolved parenchyma, 1 frag, RSS. Micro E17: Pericardium with tumor, 2 frags, RSS. Part F, ""#6. Omental biopsy"", consists of tan/yellow soft tissue and lobulated. adipose tissue (13.5 x 12 x 0.3 cm) with few scattered firm tan/white nodules. (up to 0.3 cm in greatest dimension) and focal hemorrhage. A representative. section of soft tissue and nodules is submitted for frozen section analysis as. FSB. Micro F1: Soft tissue and nodule, FSB remnant, 1 frag, ESS. Micro F2: Soft tissue and nodules, 2 frags, RSS. Part G, ""#7. Level 7"", consists of two tan/brown soft tissue fragments (1.3 x. 1.1 x 0.7 cm in aggregate). The specimen is entirely submitted for histologic. examination. Micro G1: Soft tissue fragments, 2 frags, ESS. Part H, ""#8. 4R"", consists of a tan/yellow soft tissue fragment (2.5 X 1.4 x. 0.8 cm) containing one potential lymph node. The specimen is entirely. submitted for histologic examination. Micro H1: Potential lymph node, 1 frag, ESS. Part I, ""#9. Omentum"", consists of yellow lobulated fibroadipose tissue (15 x. 12.2 x 4.5 cm) with no masses grossly identified. Representative sections are. submitted for histologic examination. Micro I1-I3: Fibroadipose tissue, 1 frag each, RSS. Page: 3 of 4. Part J, ""#10. Chest wall"", consists of a soft tissue fragment (5.1 x 2.8 x 1.4. cm) with a smooth glistening serosalized surface (6.3 X 2.8 cm) that is 80%. covered by tan/white nodules (up to 1.4 cm in greatest dimension) The. remainder of the specimen is tan/brown/pink soft tissue mixed with red/brown. ragged skeletal muscle. Micro J1-J3: Nodules with underlying soft tissue, 1 frag each, RSS. Part K, ""#11. Port site #2"", consists of two soft tissue fragments (4.1 x 3.5 x. 1.7 cm) containing skin (2.1 x 0.9 cm) and underlying soft tissue up to a depth. of 3.5 cm. There are no masses or lesions identified. Micro K1: Skin and underlying soft tissue, 1 frag, RSS. Micro K2: Underlying soft tissue, 1 frag, RSS. Micro K3: Additional soft tissue fragment, 1 frag, RSS. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto.","The test results show that the patient has diffuse malignant mesothelioma, epithelioid type, involving the chest wall, parietal pleura, mediastinal pleura, and diaphragmatic pleura. The tumor is present at all resection margins and has a maximal thickness of 4cm. Lymphovascular invasion is not identified. Metastatic mesothelioma is present in 1 of 1 lymph node from the diaphragmatic lymph nodes and 2 of 2 lymph nodes from the intraparenchymal lymph nodes. The AJCC Classification (7th edition) is ypT4N2M1. The microscopic description shows epithelioid malignant mesothelioma present in small nests in the bronchial resection margin soft tissue, and metastatic malignant mesothelioma in the omental biopsy and chest wall. The microscopic examination of the specimens from the port site 1, rib, level 9, level 8, and level 7 lymph nodes show no evidence of malignancy.","The test results show that the patient has diffuse malignant mesothelioma, epithelioid type, involving the chest wall, parietal pleura, mediastinal pleura, and diaphragmatic pleura. The tumor is present at all resection margins and has a maximal thickness of 4cm. Lymphovascular invasion is not identified. Metastatic mesothelioma is present in 1 of 1 lymph node from the diaphragmatic lymph nodes but is absent in 2 of 2 intraparenchymal lymph nodes. The AJCC Classification (7th edition) is ypT4N2M1. The microscopic description shows epithelioid malignant mesothelioma present in small nests in the bronchial resection margin soft tissue, and metastatic malignant mesothelioma in the omental biopsy and chest wall."
TCGA-DX-A1L3,TCGA-DX-A1L3.2E82135A-E73A-4A74-8A01-B610AE65FC37,"1. 7. Service: Gastric & Mixed Tumo. Specimens Submitted: 1: SP: Radical resection right peritoneal liposarcom. DIAGNOSIS: 1. SOFT TISSUE, RETROPERITONEUM, RIGHT; RESECTION: - DEDIFFERENTIATED LIPOSARCOMA. SEE NOTE. - TUMOR SIZE: 20.0 x 15.5 x 14.5 CM. - NECROSIS COMPRISES ABOUT 20-25% OF THE TUMOR VOLUME (GROSS ESTIMATE). A SMALL COMPONENT OF WELL DIFFERENTIATED LIPOSARCOMA , LIPONA-LIKE IS. PRESENT. - TUMOR IS FOCALLY PRESENT AT INKED MARGIN. NOTE: THE DEDIFFERENTIATED COMPONENT HAS A TOM FTPROSARCOMA-LIKE. APPEARANCE SIMILAR TO PREVIOUS MATERIAL. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1.) The specimen is received fresh labeled ""radical resection of right. peritoneal liposarcoma' and consists of a rubbery nodular mass measuring. 20.0 x 15.5 x 14.5 cm. The tumor is surrounded by soft fibrous membrane and. portions of fibroadipose tissue are attached. Sectioning reveals tan white. whorled cut surface with central area of necrosis involving about 20 to 25%. of the tumor volume. The surgical margin is inked black. TPS is taken. Gross photograph is taken. Representative sections are submitted. Summary of sections: Service: Gastric & Mixed Tumo. Account #: : TM - tumor to margin. T tumor. TN - tumor necrosis. Summary of Sections: Part 1: SP: Radical resection right peritoneal liposarcom. Block. Sect. Site. PCa. 1. {not entered}. 9. T. 9. 5. TM. 5. 5. TN. 5.","The specimen consists of a 20.0 x 15.5 x 14.5 cm rubbery nodular mass with a tan white whorled cut surface and central area of necrosis involving about 20-25% of the tumor volume. Microscopically, the tumor is composed of a dedifferentiated liposarcoma with a tumor-to-margin distance of 5mm and tumor necrosis of 5%. The tumor has a liposarcoma-like appearance with a component of well-differentiated liposarcoma. The dedifferentiated component has a myxofibrosarcoma-like appearance similar to previous material. The diagnosis is dedifferentiated liposarcoma.","The specimen consists of a 20.0 x 15.5 x 14.5 cm rubbery nodular mass with a tan white whorled cut surface and central area of necrosis involving about 20-25% of the tumor volume. Microscopically, the tumor is composed of a dedifferentiated liposarcoma. The tumor has a liposarcoma-like appearance with a component of well-differentiated liposarcoma. The diagnosis is dedifferentiated liposarcoma."
TCGA-PK-A5HA,TCGA-PK-A5HA.B98EC873-CB6D-4395-A473-C46EC4D2DB00,"LABORATORY MEDICINE PROGKAM. M. Facility: Specimen(s) Received. 1. Adrenal: resection adrenal mass left. 2. Fat. Diagnosis. 1. Adrenal cortical carcinoma: Adrenal. No pathological diagnosis: Lymph node, periadrenal. - (left) adrenalectomy specimen. 2. No pathological diagnosis: Adipose tissue, (site not listed) excisional biopsy. Comment. The morphological and immunohistochemical features are consistent with an adrenocortical carcinoma. Synoptic Data. Neoadjuvant Therapy: Clinical History: Other: left side pain. Tumor Site: Adrenal structure. Adrenal Gland Received: Fresh. Procedure: Adrenalectomy, total. Specimen Integrity: Intact. Specimen Size: Greatest dimension: 7.0 cm. Additional dimension: 6.0 cm. Additional dimension: 5.0 cm. Specimen Laterality: Left. Tumor Size: Greatest dimension: 5.0 cm. Additional dimension: 4.4 cm. Additional dimension: 4.0 cm. Tumor gland weight: 47.3 g. Histologic Type: Adrenal cortical carcinoma. Margins: Margins uninvolved by tumor. Treatment Effect: Not identified. Lymph-Vascular Invasion: Present, small vessel (capillary lymphatic). Perineural Invasion: Not identified. Ancillary Studies: Types: IHC. Results: The tumor is strongly positive for calretinin, synaptophysin and Melan A. (A103). There is variable positivity for LMWK (CAM 5.2), inhibin, CD10. (cytoplasmic) and p53. Stains for EMA, S100, and chromogranin are negative. MIB-1 LI is 20%. TNM Descriptors: Not applicable. Primary Tumor (pT): pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of Nodes examined: 1. Number of Nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Tumor necrosis. Degenerative changes, Hemorrhage. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Clinical History. Left adrenal adenoma. Gross Description. 1. The specimen labeled with the patient's name and as ""resection adrenal gland mass left"" contains an adrenal gland. with surrounding fibroadipose tissue. The specimen measures 7.0 x 6 .0 x 5.0 cm and weighs 70.2 g. The surface is. painted with silver nitrate and the fat is removed. The adrenal gland measures 5.2 x 4.0 x 5.0 cm and weighs 47.3g. On. section, there is a well-circumscribed multilobulated mass that measures 4.4 x 4.0 x 5.0 cm. The cut surface of the tumor. has a variegated light brown to tan color, solid and firm. The rest of the adrenal tissue is unremarkable grossly. The tumor. and normal tissue are stored frozen. The adrenal tissue is submitted as follows: 1A-AG adrenal gland serially sectioned and submitted in toto. 2. The. specimen labeled with the patient's name and as ""fat"" contains a single piece of a grossly unremarkable. fibroadipose tissue that measures 5.5 x 2.2 x 1.7 cm. 2A. representative sections. ;ription. Fuhrman Nuclear Grade: IV. Necrosis: Present, predominantly single cell necrosis. Mitotic activity: >5 mitoses /50 high power fields. Atypical mitosis: Present. Growth pattern: Solid and diffuse. Cell type: Eosinophilic, > %90. Lymphovascular invasion: Present, sinusoidal type. Capsule invasion: Present, focal. Immunohistochemistry: The tumor is strongly positive for calretinin, synaptophysin and Melan A (A103). There is variable. positivity for LMWK (CAM 5.2), inhibin, CD10 (cytoplasmic) and p53. Stains for EMA, S100, and chromogranin are. negative. MIB-1 LI is 20%.","The patient underwent an adrenalectomy for a left adrenal mass. The microscopic description revealed a well-circumscribed, multilobulated mass with a variegated light brown to tan color, solid and firm texture. The tumor measured 4.4 x 4.0 x 5.0 cm and weighed 47.3g. Histologically, the tumor was classified as an adrenal cortical carcinoma, Fuhrman Nuclear Grade IV, with features of solid and diffuse growth pattern, eosinophilic cell type (>90%), single cell necrosis, >5 mitoses/50 high power fields, atypical mitosis, lymphovascular invasion, and focal capsule invasion. Immunohistochemical studies showed strong positivity for calretinin, synaptophysin, and Melan A, with variable positivity for LMWK, inhibin, CD10, and p53, and negativity for EMA, S100, and chromogranin. The MIB-1 LI was 20%. The tumor margins were uninvolved by tumor, and there was no regional lymph node metastasis.","The patient underwent an adrenalectomy for a left adrenal mass. The microscopic description revealed a well-circumscribed, multilobulated mass with a variegated light brown to tan color, solid and firm texture. The tumor measured 4.4 x 4.0 x 5.0 cm. Histologically, the tumor was classified as an adrenal cortical carcinoma, Fuhrman Nuclear Grade IV, with features of solid and diffuse growth pattern, eosinophilic cell type (>90%), single cell necrosis, >5 mitoses/50 high power fields, atypical mitosis, lymphovascular invasion, and focal capsule invasion. Immunohistochemical studies showed strong positivity for calretinin, synaptophysin, and Melan A, with variable positivity for LMWK, inhibin, CD10, and p53, and negativity for EMA, S100, and chromogranin. The MIB-1 LI was 20%. The tumor margins were uninvolved by tumor, and there was no regional lymph node metastasis."
TCGA-IQ-7632,TCGA-IQ-7632.4e2a322d-2323-40bc-bb05-55f4ccea9298,"SPECIMEN ID: A. NECK, NOS - LEFT NECK DISSECTION LEVEL 1,. B. NECK, NOS - LEFT NECK DISSECTION LEVEL 2 AND 3,. c. NECK, NOS - LEFT SUBMENTAL TRIANGLE NECK DISSECTION,. D. MANDIBLE, NOS - LEFT COMPOSITE RESECTION, E. MANDIBLE, NOS - PROXIMAL MANDIBLE FS,. F. MANDIBLE, NOS - DISTAL MANDIBLE FS, G. MOUTH - ANTERIOR FLOOR OF MOUTH,. H. MOUTH - LEFT RETROMOLAR TRIGONE , I. MOUTH - POSTERTOR FLOOR OF MOUTH,. J. MOUTH - LEFT ANTERIOR BUCCAL MUCOSA, K. MOUTH - LEFT BUCCAL MUCOSA POSTERIOR,. L. MUCOUS MEMBRANE, NOS - ADDITIONAL GINGIVAL BUCCAL MUCOSA NOT A MARGIN,. M. MOUTH  LEFT GINGIVAL BUCCAL SOLSTICE, N. MOUTH - LEFT LINGUAL ALVEOLAR RIDGE,. o. TONGUE - TONGUE, P. MOUTH - PTERYGOID,. Q. MANDIBLE, NOS - ADDITIONAL MANDIBLE BONE AND TISSUES, R. TOOTH - # 23 TOOTH. A. LEFT NECK DISSECTION, LEVEL 1: Lymph nodes (2) ; negative for tumor. Parotid gland; no specific pathologic changes. B. LEFT NECK DISSECTION, LEVELS 2 AND 3: Lymph nodes (25) 1 negative for tumor. C. LEFT COMPOSITE RESECTION: Lymph nodes (3) ; negative for tumor,. D. LEFT COMPOSITE RESECTION: FINAL DIAGNOSIS. Invasive, well-differentiated squamous cell carcinoma; 5.5 cm. Tumor invades up to mandibular bone,. Margins negative for tumor. Osteonecrosis. E. PROXIMAL MANDIBLE: No malignancy seen. F. DISTAL MANDIBLE: No malignancy seen. ANTERIOR FLOOR OF MOUTH: No malignancy seen. H. LEFT RETROMOLAR TRIGONE: No malignancy seen,. POSTERIOR FLOOR OF MOUTH: No malignancy seen. LEFT ANTERIOR BUCCAL MUCOSA: No malignancy seen. K. LEFT BUCCAL MUCOSA POSTERIOR: No malignancy seen. L. ADDITIONAL GINGIVAL BUCCAL MUCOSA (NOT A MARGIN) : FINAL DIAGNOSIS. NO malignancy seen,. M. LEFT GINGIVAL BUCCAL SOLSTICE: No malignancy seen. N. LEFT LINGUAL ALVEOLAR RIDGE: No malignancy seen,. TONGUE: No malignancy seen. P. PTERYGOID: No malignancy seen,. Q. ADDITIONAL LEFT MANDIBULAR BONE AND TISSUE: Bone with osteonecrosis. No evidence of malignancy. R. TOOTH #23: Gross only. CLINICAL HISTORY-. PRE-OP DX: Not provided. PROCEDURE: Not provided. RELEVANT CLINICAL HX: Not provided. GROSS DESCRIPTION: A. Received in formalin and labeled ""Left neck dissection Level 1"" is a fibroadipose. tissue which measures 5.0 x 4.0 x 3.5 cm. Sectioning reveals a salivary gland which. measures 3.0 x 4.0 x 1.5 cm. Largest lymph node measures 1.5 x 1.5 x 1.0 cm. Sections. submitted as follows: Cassette #1: Largest lymph node bisected. Cassette #2: One lymph node bisected. Cassette #3: Representative section of salivary gland. B. Received in formalin and labeled ""Left neck dissection, levels 2 & 3"" is a. fibroadipose tissue fragment which measures 7.5 x 5.0 x 3.0 cm. There is a stitch at. one end. The largest lymph node from the half with the stitch measures 2.5 x 1.5 x 1.0. cm. The internal surface of that lymph node has focal. areas of hemorrhage and areas. that are brown to white, Largest lymph node opposite to the stitch measures 1.5 x 1.0. x 0.7 cm. Cassettes submitted as follows: Cassettes #1-10: Lymph nodes from the section from the suture stitch. Cassettes #1&2: Representative sections from largest lymph node. Cassette #3 Four possible lymph nodes. Cassette #4: Four possible lymph nodes. Cassette #5: Four possible lymph nodes. Cassette #6: One lymph node bisected. Cassette #7: Three possible lymph nodes. Cassette #8: One lymph node bisected. Cassette #9: One lymph node bisected. Cassette #10: One lymph node bisected. Cassettes #11&12: Section opposite to the suture. Cassette #11: Five possible lymph node. Cassette #12: One lymph node bisected. C. Received in formalin and labeled ""Left submental neck dissection"" is a fibroadipose. tissue which measures 4.0 x 2.5 x 1.5 cm. Largest lymph node measures 1,0 x 0.7 x 0.5. cm. Sections submitted as follows: Cassette #1: Three possible lymph nodes. Cassette #2: Largest lymph node bisected. D. Received in formalin and labeled ""Lefft composite resection"" i.s a right mandible with. fibroadipose tissue connected, teeth and buccal mucosa. Specimen measures 7.5 x 4,0 x. 3.0 cm. There are four teeths. One molar, two premolar, one. There is a large. exophytic mass located both on the medial and lateral surfaces of. the specimen. It. GROSS DESCRIPTION: (Continued). measures 5.5 x 3.5 x 4.0 cm. The lesion appears to invade the mandible and invade the. teeth. Sections submitted as follows: Cassettes #1&2: Composite section of anterior bone margin in composite. Cassette #1: Superior end. Cassette #2: Inferior end. Cassettes #3&4: Composite section of posterior bony margin. Cassette #3 Superior end. Cassette #4: Inferior end. Cassette #5: Mucosal margin from the lateral buccal surface on the posterior aspect of. the specimen. Cassettes #6&7: Composite section of representative section of lesion. Cassette #6: Mandible with tumor on medial surface. Cassette #7: Mandible with tumor on lateral surface. Cassette #8: Representative section of tumor with mandible and buccal mucosa on. lateral surface. Cassette #9: Representative section of tumor with buccal mucosa on lateral surface. Cassettes #10&11: Composite section of tumor with mandible and attached soft tissue. Cassette #10: Medial surface. Cassette #11: Tumor with lateral surface. Cassette #12: Additional representative section of tumor. Note: Cassettes #1,2,3,4,6,7,8,10,11 are submitted for decalcification. E. Received fresh and labeled ""Proximal mandible"" is a soft tissue fragment which. measures 0.5 x 0.4 x 0.2 cm. Tissue is tan/white and hard. Submitted in toto in one. cassette for frozen section. F. Received fresh and labeled ""Distal mandible"" is a tan/white, hard tissue fragment. which measures 0.5 x 0.5 x 0.3 cm. Submitted in toto in one cassette for frozen. section. G. Received fresh and labeled ""Anterior floor of mouth"" is a tan/pink, soft tissue. fragment which measures 3.0 x 0.5 x 0.5 cm. Submitted in toto in one cassette for. frozen section. H. Received fresh and labeled ""Left retromolar trigone"" is a tan/pink, soft tissue. measuring 2.0 x 0.5 x 0.5 cm. Submitted in toto in one cassette for frozen section. I. Received fresh and labeled ""Posterior floor of mouth"" is a tan/pink, soft tissue. fragment which measures 3.0 x 0.4 x 0.4 cm. Submitted in toto in one cassette for. frozen section,. GROSS DESCRIPTION: Received fresh and labeled ""Left anterior buccal mucosa"" is a tan/pink, soft tissue. fragment which measures 3.5 x 0.5 x 0.3 cm. Submitted in toto in one cassette for. frozen section. K. Received fresh and labeled ""Left buccal mucosa posterior"" are three fragments of. tan/pink, soft tissue fragments which measures 1.0 x 1.0 x 0.5 cm in aggregate. Submitted in toto in one cassette for frozen section. L. Received in formalin and labeled ""Additional gingival buccal mucosa, not a margin"" is. a soft tissue, tan tissue fragment which measures 1,4 x 0.5 x 0.2 cm. Submitted in. toto in one cassette. M. Received fresh and labeled ""Left gingival buccal solstice"" is a tan/pink, soft tissue. fragment which measures 1. 8 x 0.3 x 0.3 cm. Submitted in toto in one cassette for. frozen section. N. Received fresh and labeled ""Left lingual alveolar ridge"" is tan/pink, sof.t tissue. fragment which measures 1.0 x 0.5 x 0.3 cm. Submitted in toto in one cassette for. frozen section. o. Received fresh and labeled ""Tongue"" is a tan/pink, soft tissue fragment which measures. 0.5 x 0.5 x 0.3 cm. Submitted in toto in one cassette for frozen section. P. Received fresh and labeled ""pterygoid"" is a tan/white firm tissue fragment which. measures 1.2 x 0.6 x 0.5 cm. Submitted in toto in one cassette for frozen section. Received in formalin and labeled ""Additional left mandibular bone and tissue"" are. multiple fragments of bone with connective soft tissue measuring 2.1 x 1.5 x 0.6 cm in. aggregate. Submitted in toto in two cassettes after decalcification. R. Received in formalin and labeled ""#/23 tooth"" is an incisor which measures 2.3 X 0.5 x. 0.5 cm. Tooth has some soft tissue attached and significant yellow on the internal. surface but is otherwise unremarkable. Gross description only. OPERATING ROOM CONSULT. E) PROXIMAL MANDIBLE. FSDX: NO MALIGNANCY SEEN. F) DISTAL MANDIBLE. FSDX: NO MALIGNANCY SEEN. G) ANTERIOR FLOOR OF MOUTH. FSDX: NO MALIGNANCY SEEN. H) LEFT RETROMOLAR TRIGONE. FSDX: NO MALIGNANCY SEEN. I) POSTERIOR FLOOR OF MOUTH. FSDX: NO MALIGNANCY SEEN. CONCURS. J) LEFT ANTERIOR BUCCAL MUCOSA. FSDX: NO MALIGNANCY SEEN. K) LEFT BUCCAL MUCOSA POSTERIOR. FSDX: NO MALIGNANCY SEEN. M) LEFT GINGIVAL BUCCAL SOSLTICE. FSDX: NO MALIGNANCY SEEN. N) LEFT LINGUAL ALVEOLAR RIDGE. NO MALIGNANCY SEEN. o) TONGUE. FSDX: NO MALIGNANCY SEEN. P) PTERYGOID. FSDX: NO MALIGNANCY SEEN.","The patient underwent a left neck dissection, composite resection, and additional tissue removal. The microscopic description revealed invasive, well-differentiated squamous cell carcinoma in the left composite resection, measuring 5.5 cm, with tumor invasion up to the mandibular bone. The margins were negative for tumor. Osteonecrosis was also noted. The lymph nodes from the left neck dissection levels 1, 2, and 3 were negative for tumor. The proximal and distal mandible, anterior floor of the mouth, left retromolar trigone, posterior floor of the mouth, left anterior buccal mucosa, left buccal mucosa posterior, left gingival buccal solstice, left lingual alveolar ridge, tongue, and pterygoid were all negative for malignancy. The additional left mandibular bone and tissue showed bone with osteonecrosis, but no evidence of malignancy. Tooth #23 was gross only, with no malignancy seen.","The patient underwent a left neck dissection, composite resection, and additional tissue removal. The microscopic description revealed invasive, well-differentiated squamous cell carcinoma in the left composite resection, measuring 5.5 cm, with tumor invasion up to the mandibular bone. The margins were negative for tumor. Osteonecrosis was also noted. The lymph nodes from the left neck dissection levels 1, 2, and 3 were negative for tumor. The proximal and distal mandible, anterior floor of the mouth, left retromolar trigone, posterior floor of the mouth, left anterior buccal mucosa, left buccal mucosa posterior, left gingival buccal solstice, left lingual alveolar ridge, tongue, and pterygoid were all negative for malignancy. The additional left mandibular bone and tissue showed bone with osteonecrosis, but no evidence of malignancy. Tooth #23 was only grossly described."
TCGA-06-5417,TCGA-06-5417.6984f96f-e27e-4143-b7db-54e97dbaa25c,"=. CLINICAL HISTORY. experienced severe left. and. some. On imaging there are two. contiguous. lesions. One is large, parasagittal in the superior left frontal, has. irregular enhancement, is probably extra axial, and is fed by a branch. of the. middle meningeal artery; this lesion is embolized. The second lesion. is. partially cystic, 5.5 cm across, and is located inferiorly in the. anterior. frontal lobe; the mass enhances slightly and exerts mass effect in the. lateral. ventricle. OPERATIVE DIAGNOSES. Brain tumors. Operation/Specimen: A: Brain, excision biopsy. B: Brain, 1, excision biopsy. C: Brain, intra-axial, excision biopsy. D: Brain, medial portion, excision biopsy. E: Brain, medial portion, excision biopsy. PATHOLOGICAL DIAGNOSIS: A and B. 1. Brain, sites not specified, excision: Meningioma (WHO I),. extensively. necrotic, previously embolized. 2. MIB-1 proliferation index: 2%. C, D, and E. Brain, intraaxial, medial portion (FS), and medial. portion-permanent, excision: 1. Glioblastoma. 2. MIB-1 proliferation index: 30% to 35%. See Microscopy Description and Comment. COMMENT. Parts A and B are portions of a fibrous meningioma that is extensively. necrotic. In the few better preserved areas the mitotic index is. about one /. ten high power fields, and the proliferation index is about 2% in the. more. active areas. There is not brain tissue in the specimens submitted. Parts C, D, and E contain portions of a glial neoplasm that heavily. infiltrates cerebral cortex and adjacent white matter. The neoplastic. cells. are very pleomorphic with frequent giant nuclei or multinucleated. cells. The. tumor has prominent nuclear anaplasia, frequent mitotic activity,. prominent. microvascular cellular proliferation, and zones of necrosis, some with. pseudopalisading. The MIB-1 proliferation index is high, up to 35%. The findings are interpreted as those of a glioblastoma (WHO grade. IV). In part C the tumor is more infiltrative. In parts D and E the. tumor is. more solid and less differentiated. PROCEDURES/ADDENDA. MGMT Promoter Methylation. Interpretation. POSITIVE: Methylated MGMT promoter is detected. lesults-Comments. Testing performed on DNA extracted from tumor paraffin block. TEST DESCRIPTION: Patients with glioma containing a methylated MGMT. promoter. have been shown to benefit from therapy with alkylating agents. Assessment of. MGMT promoter methylation status involves bisulfite treatment of DNA. followed. by real-time PCR amplification (MethyLight) of methylated and. unmethylated DNA. sequences. The analytic sensitivity of this assay was determined by. serial. dilution of methylated positive control DNA into unmethylated DNA, and. was. assessed to be 1% of methylated DNA in the background of unmethylated. DNA. Factors such as the presence of >50% non-neoplastic cells in the. sample, or. extensive tissue necrosis, may preclude the detection of methylated. MGMT. promoter sequences. FDA COMMENT: The above data are not to be construed as the results. from a. stand alone diagnostic test. This test was developed and its. performance. characteristics determined by the. laboratory as. required by CLIA. regulations. It has not been cleared or approved. for. specific uses by the U.S. Food and Drug Administration (FDA) The FDA. has. determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted. only in. the context of established procedures and/or diagnostic criteria. POSITIVE: Allelic loss on chromosome arm 19q is detected. Allelic loss on chromosome arm 1p is not detected. Informative loci are: D1S548, D1S1592, D1S552, D19S219, and PLA2G4C. Results-Comments. TEST DESCRIPTION: Allelic loss is assessed by PCR assay in Normal DNA. (baseline) / Tumor DNA pairs using 3 markers at both 1p and 19q. The 3. markers. on 1p are D1S548, D1S1592, and D1S552 (with D1S468, D1S1612, and. D1S496 as. backup markers) and the 3 markers on 19q are D19S219, D19S412, and. PLA2G4C. (with D19S606 and D19S1182 as backup) All markers are microsatellites. (2 or 4. nt repeats) except PLA2G4C which is a minisatellite (26 nt repeat). polymorphism. The markers were selected based on heterozygosity score,. amplicon size, and ease of interpretation. The backup markers are used. if the. first line markers at that chromosome arm are uninformative or. otherwise. ambiguous in their interpretation. LOH at all informative loci on each. chromosomal arm represents the typical finding in oligodendrogliomas. with 1p. and 19q deletion. FDA COMMENT: The above data are not to be construed as the results. from a. stand-alone diagnostic test. This test was developed and its. performance. characteristics determined by the. laboratory as. required by CLIA. regulations. It has not been cleared or. approved for. specific uses by the U.S. Food and Drug Administration (FDA) . The FDA. has. determined that such clearance or approval is not necessary. These. results are. provided for informational purposes only, and should be interpreted. only in. the context of established procedures and/or diagnostic criteria. TECHNICAL SENSITIVITY: The presence of >15% non-neoplastic cells in. the sample. may preclude the detection of allelic loss. INTRA-OPERATIVE CONSULTATION. A. Brain, excision biopsy: Necrotic tumor, probably epithelioid (C/W. meningioma,. other). Touch preparation smears performed at. and. results reported to the Physician of Record. C. Brain, intra-axial, excision biopsy: Primary brain tumor, glial, high. histological grade (R/O oligo component, other) . Touch. preparation. smears performed at. and results reported to the. of Record. GROSS DESCRIPTION. A. ""Meningioma"", received fresh, portion of capsule, 2.0 cm across,. containing. soft, creamy, greyish-white necrotic material. In total, A1 and A2. B. ""Meningioma, permanent,"" received fresh multiple fragments, 2.5 x 1.8. X 0.7. cm. Diffluent, creamy-white, necrotic. In total, B1-B3. C. ""Intraaxial tumor, 11 received fresh, four fragments, 1.0 cm in. aggregate. Semi. firm, greyish-pink, glistening. In total, C1 and C2. D. ""Medial portion (FS), received fresh, two fragments, 2.5 cm across in. aggregate. Firm, greyish-white, smooth cut surfaces. In total, D1-. D3. E. ""Medial portion, permanent"", received fresh, three fragments, 2.7 cm. across in. aggregate. Firm, tannish-white, smooth cut surfaces. In total, E1-. E3. MICROSCOPIC DESCRIPTION. IMMUNOHISTOCHEMISTRY: The meningeal tumor has positive reaction with EMA. With the MIB-1,. the. proliferation index is about 2%; around zones of necrosis, it may be. somewhat. higher, as may be expected in tumors with embolization-induced. necrosis. In the intra axial tumor, the GFAP demonstrates a dense gliofibrillary. background throughout the specimen, even in the more cellular, less. differentiated zones of the neoplasm. The synaptophysin and. neurofilament. depict the tumor densely infiltrating cerebral cortex and adjacent. white. matter, and absence of a neuronal neoplastic component. The great. majority of. neoplastic cells strongly over express the p53 protein. With the MIB-. 1 the. proliferation index ranges between 30% and 35% in the more densely. infiltrated. areas. ICD-9( (s) : Histo Data. Part A: Brain, excision biopsy. Stain/cnt. Block. Comment. H/E X 1. 1. TPS H/E X 1. H/E X 1. 2. Part B: Brain, 1, excision biopsy. Stain/cnt. Block. Comment. EMA-DA x 1. 1. H/E X 1. MIB1-DA x 1. 1. H/E X 1. 2. H/E X 1. 3. Part C: Brain. intra-axial, excision biopsy. Stain/cnt. Block. Comment. H/E x 1. 1. TPS H/E x 1. 1. H/E x 1. 2. Part D: Brain, medial portion, excision biopsy. Stain/cnt. Block. Comment. X 1. 1. 1p, 19q LOH. No. microdissection. CD34-DA X 1. 1. mGFAP-DA x 1. 1. H/E X 1. 1. MGMT-curls X 1. 1. MIB1-DA X 1. NeuN X 1. 1. NF2F11 X 1. 1. P53D07 X 1. 1. Synap-DA X 1. 1. TPS H/E X 1. 1. H/E X 1. 2. H/E X 1. 3. Part E: Brain, medial portion, excision biopsy. Stain/cnt. Block. Comment. H/E x 1. 1. H/E x 1. 2. mGFAP-DA x 1. 3. H/E X 1. 3. MIB1-DA X 1. 3. NF2F11 X 1. 3.","The patient underwent a brain tumor excision biopsy with multiple specimens submitted for pathological examination. The results of the microscopic description are as follows: The meningeal tumor (specimens A and B) is a fibrous meningioma (WHO Grade I) with extensive necrosis, previously embolized, and a MIB-1 proliferation index of 2%. The tumor cells are positive for EMA and show a mitotic index of about one per ten high power fields. The intra-axial tumor (specimens C, D, and E) is a glioblastoma (WHO Grade IV) with a high MIB-1 proliferation index of 30-35%. The tumor cells are densely infiltrating cerebral cortex and adjacent white matter, with prominent nuclear anaplasia, frequent mitotic activity, microvascular cellular proliferation, and zones of necrosis. The tumor cells are positive for GFAP, synaptophysin, and neurofilament, and strongly overexpress the p53 protein. The MGMT promoter is methylated, indicating a potential benefit from therapy with alkylating agents. Allelic loss on chromosome arm 19q is detected, which is a typical finding in oligodendrogliomas with 1p and 19q deletion.","The patient underwent a brain tumor excision biopsy with multiple specimens submitted for pathological examination. The results of the microscopic description are as follows: The meningeal tumor (specimens A and B) is a fibrous meningioma (WHO Grade I) with extensive necrosis, previously embolized, and a MIB-1 proliferation index of 2%. The tumor cells are positive for EMA and show a mitotic index of about one per ten high power fields. The intra-axial tumor (specimens C, D, and E) is a glioblastoma (WHO Grade IV) with a high MIB-1 proliferation index of 30-35%. The tumor cells are densely infiltrating cerebral cortex and adjacent white matter, with prominent nuclear anaplasia, frequent mitotic activity, microvascular cellular proliferation, and zones of necrosis. The tumor cells are positive for GFAP, synaptophysin, and neurofilament, and strongly overexpress the p53 protein. The MGMT promoter is methylated, indicating a potential benefit from therapy with alkylating agents. Allelic loss on chromosome arm 19q is detected."
